(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
| Title | Journal |
|---|---|
| ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. | Toxicology and applied pharmacology 20171215 |
| Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite. | Toxicology 20171201 |
| Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings? | Toxicology 20161130 |
| Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy. | Basic & clinical pharmacology & toxicology 20161101 |
| Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. | Archives of toxicology 20160101 |
| Chemical profiling of the genome with anti-cancer drugs defines target specificities. | Nature chemical biology 20150701 |
| Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1. | Chemico-biological interactions 20150605 |
| Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells. | Chemico-biological interactions 20140805 |
| Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line. | Toxicology in vitro : an international journal published in association with BIBRA 20140301 |
| Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits. | Toxicology 20130915 |
| Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy. | European journal of pharmacology 20130815 |
| S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity. | Chemico-biological interactions 20130225 |
| A case report of acute myeloid leukemia after liver transplantation. | Acta haematologica 20130101 |
| Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells. | BMC pharmacology & toxicology 20130101 |
| Determining DNA supercoiling enthalpy by isothermal titration calorimetry. | Biochimie 20121201 |
| Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. | Bioorganic & medicinal chemistry 20121115 |
| Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407. | Pediatric blood & cancer 20121101 |
| A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions? | Journal of pediatric hematology/oncology 20121101 |
| Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways. | The Journal of pharmacology and experimental therapeutics 20121101 |
| Polysaccharides as a source of advanced materials: cellulose hollow microspheres for drug delivery in cancer therapy. | Journal of colloid and interface science 20121015 |
| Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121010 |
| Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group. | Cancer 20121001 |
| Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia. | Leukemia research 20121001 |
| Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation. | British journal of haematology 20121001 |
| Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia. | Leukemia research 20121001 |
| Progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: design, synthesis, characterization and biological evaluation. | Steroids 20121001 |
| Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study. | International journal of hematology 20121001 |
| Understanding the binding of daunorubicin and doxorubicin to NADPH-dependent cytosolic reductases by computational methods. | European journal of medicinal chemistry 20121001 |
| Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis. | Anticancer research 20121001 |
| Antileukaemia effect of rapamycin alone or in combination with daunorubicin on Ph+ acute lymphoblastic leukaemia cell line. | Hematological oncology 20120901 |
| Nine years interval between first and second bone marrow transplantations and subsequent long-term survival--a case of acute myeloid leukemia with MLL-AF6 fusion gene. | Annals of hematology 20120901 |
| Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia. | Leukemia & lymphoma 20120901 |
| Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia. | Cytometry. Part B, Clinical cytometry 20120901 |
| Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients. | Annals of hematology 20120901 |
| Numb chin syndrome in acute myeloid leukemia. | The American journal of the medical sciences 20120901 |
| In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120901 |
| Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. | The Lancet. Oncology 20120901 |
| Role of orbitofrontal cortex neuronal ensembles in the expression of incubation of heroin craving. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120822 |
| Electrochemical assay of concanavalin A-ovalbumin binding on magnetic beads. | The Analyst 20120821 |
| Acid-base catalysis of N-[(morpholine)methylene]daunorubicin. | Drug development and industrial pharmacy 20120801 |
| Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). | Annals of hematology 20120801 |
| Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710 |
| Going beyond 7 + 3 regimens in the treatment of adult acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710 |
| Probing the binding of two sugar bearing anticancer agents aristololactam-β-(D)-glucoside and daunomycin to double stranded RNA polynucleotides: a combined spectroscopic and calorimetric study. | Molecular bioSystems 20120706 |
| Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. | Haematologica 20120701 |
| Evidence for the genotoxic effect of daunomycin in multipotent hematopoietic cells of mouse bone marrow: chromatin proteins analysis. | Journal of pharmaceutical and biomedical analysis 20120701 |
| Oxazolinodoxorubicin - a promising new anthracycline. | Anticancer research 20120701 |
| Drug shortages delay cancer clinical trials. | Journal of the National Cancer Institute 20120620 |
| Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. | Cell cycle (Georgetown, Tex.) 20120615 |
| Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines. | International journal of laboratory hematology 20120601 |
| Effect of nitric oxide on the daunorubicin efflux mechanism in K562 cells. | Cell biology international 20120601 |
| Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine. | Leukemia research 20120601 |
| The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers. | Journal of liposome research 20120601 |
| GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate. | European journal of medicinal chemistry 20120601 |
| Metabolic monosaccharides altered cell responses to anticancer drugs. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120601 |
| [Effect of proliferation inhibition and PTEN gene expression induced by decitabine combined with daunorubicin on HL-60 cell line]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20120601 |
| Novel PLA modification of organic microcontainers based on ring opening polymerization: synthesis, characterization, biocompatibility and drug loading/release properties. | International journal of pharmaceutics 20120530 |
| Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia. | Cancer chemotherapy and pharmacology 20120501 |
| [Lethal pulmonary hemorrhage caused by Stenotrophomonas maltophilia pneumonia in a patient with acute myeloid leukemia]. | Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20120501 |
| [Effect of arsenic trioxide and daunorubicin on procoagulant activity of acute promyelocytic leukemia cells]. | Zhonghua yi xue za zhi 20120424 |
| Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20120401 |
| Unexpected pancytopenia following treatment of acute lymphoblastic leukemia. | American journal of hematology 20120401 |
| Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells. | Cell biology and toxicology 20120401 |
| Are low-intensity induction strategies better for older patients with acute myeloid leukemia? | Leukemia research 20120401 |
| The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL). | Hematology (Amsterdam, Netherlands) 20120401 |
| Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells. | Biochemical and biophysical research communications 20120316 |
| High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China. | Medical oncology (Northwood, London, England) 20120301 |
| Intercalation and induction of strand breaks by adriamycin and daunomycin: a study with human genomic DNA. | DNA and cell biology 20120301 |
| Doxorubicin- and daunorubicin-induced regulation of Ca2+ and H+ fluxes through human bax inhibitor-1 reconstituted into membranes. | Journal of pharmaceutical sciences 20120301 |
| Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia. | American journal of hematology 20120301 |
| New induction and postinduction strategies in acute myeloid leukemia. | Current opinion in hematology 20120301 |
| miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2. | Acta biochimica et biophysica Sinica 20120301 |
| Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. | Journal of medicinal chemistry 20120223 |
| AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. | Cancer 20120201 |
| Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling. | Cancer science 20120201 |
| Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy. | International journal of hematology 20120201 |
| Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells. | Archives of pharmacal research 20120201 |
| Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20120101 |
| Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association. | American journal of hematology 20120101 |
| Acute isolated transmural neutropenic gastritis. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101 |
| Diffuse osteosclerosis-associated acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101 |
| Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1. | Journal of translational medicine 20120101 |
| Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia. | Acta haematologica 20120101 |
| Impact of environmental parameters on the activity of the P-glycoprotein. | Advances in experimental medicine and biology 20120101 |
| Daunorubicin-TiO2 nanocomposites as a 'smart' pH-responsive drug delivery system. | International journal of nanomedicine 20120101 |
| Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes. | Diagnostic pathology 20120101 |
| Synthesis and biological activities of a 3'-azido analogue of Doxorubicin against drug-resistant cancer cells. | International journal of molecular sciences 20120101 |
| Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. | International journal of nanomedicine 20120101 |
| Tautomerism in 11-hydroxyaklavinone: a DFT study. | TheScientificWorldJournal 20120101 |
| [Studies by means of 1H NMR spectroscopy of complex formation of aromatic biologically active compounds with antibiotic topotecan]. | Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20120101 |
| Tuning the drug efflux activity of an ABC transporter in vivo by in vitro selected DARPin binders. | PloS one 20120101 |
| Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. | International journal of nanomedicine 20120101 |
| Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line. | International journal of nanomedicine 20120101 |
| [High-density lipoproteins as a form of daunorubicin transport in hepatoma cells of mice]. | Eksperimental'naia i klinicheskaia farmakologiia 20120101 |
| Influence of chemotherapy on the lipid peroxidation and antioxidant status in patients with acute myeloid leukemia. | Acta medica Iranica 20120101 |
| [The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia]. | Terapevticheskii arkhiv 20120101 |
| Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. | Mediators of inflammation 20120101 |
| A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ. | PloS one 20120101 |
| Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study. | Blood 20111215 |
| Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect. | Journal of controlled release : official journal of the Controlled Release Society 20111210 |
| The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin. | Toxicology in vitro : an international journal published in association with BIBRA 20111201 |
| Circadian clock protein BMAL1 regulates cellular senescence in vivo. | Cell cycle (Georgetown, Tex.) 20111201 |
| Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. | Cell death & disease 20111201 |
| [A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20111201 |
| Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials. | Blood 20111124 |
| Oligonucleotide stabilized silver nanoclusters as fluorescence probe for drug-DNA interaction investigation. | Analytica chimica acta 20111114 |
| Noncovalent DNA binding drives DNA alkylation by leinamycin: evidence that the Z,E-5-(thiazol-4-yl)-penta-2,4-dienone moiety of the natural product serves as an atypical DNA intercalator. | Journal of the American Chemical Society 20111109 |
| In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells. | Leukemia research 20111101 |
| High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse. | Haematologica 20111101 |
| Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. | British journal of haematology 20111101 |
| Eccrine hidradenitis sine neutrophils: a toxic response to chemotherapy. | Journal of cutaneous pathology 20111101 |
| Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. | Oncotarget 20111101 |
| A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia. | Blood 20111006 |
| Micellar electrokinetic chromatographic analysis for in vitro accumulation of anthracyclines enhanced by inhibitors of cell membrane transporter-proteins in cancer cells. | Biomedical chromatography : BMC 20111001 |
| Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. | Pediatric blood & cancer 20111001 |
| Treatment strategies in patients with core-binding factor acute myeloid leukemia. | Current oncology reports 20111001 |
| ABC transporters influence sensitivity of Brugia malayi to moxidectin and have potential roles in drug resistance. | Experimental parasitology 20111001 |
| Understanding and treating opioid addiction in a patient with cancer pain. | The journal of pain : official journal of the American Pain Society 20111001 |
| Proteomic approach to enhance doxorubicin production in panK-integrated Streptomyces peucetius ATCC 27952. | Journal of industrial microbiology & biotechnology 20110901 |
| Multiple actions of the anthracycline daunorubicin on cardiac ryanodine receptors. | Molecular pharmacology 20110901 |
| YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. | International journal of cancer 20110901 |
| Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1. | Oncotarget 20110901 |
| Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues. | Journal of medicinal chemistry 20110825 |
| Acute myeloid leukaemia: optimal management and recent developments. | Drugs 20110820 |
| AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group. | Toxicology and applied pharmacology 20110815 |
| Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. | Blood 20110811 |
| Siblings presenting with progressive congenital aleukemic leukemia cutis. | Pediatric blood & cancer 20110801 |
| A structural analysis of G-quadruplex/ligand interactions. | Biochimie 20110801 |
| Successful treatment of childhood Philadelphia chromosome-positive acute myeloid leukemia. | Pediatrics international : official journal of the Japan Pediatric Society 20110801 |
| Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia. | Journal of genetics 20110801 |
| Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4. | Bioconjugate chemistry 20110720 |
| No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy. | Pediatric blood & cancer 20110715 |
| Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours. | Pediatric blood & cancer 20110715 |
| Detection of daunomycin using phosphatidylserine and aptamer co-immobilized on Au nanoparticles deposited conducting polymer. | Biosensors & bioelectronics 20110715 |
| Electrochemically monitoring the binding of concanavalin A and ovalbumin. | Talanta 20110715 |
| Sacrificial template-directed fabrication of superparamagnetic polymer microcontainers for pH-activated controlled release of Daunorubicin. | Langmuir : the ACS journal of surfaces and colloids 20110705 |
| Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. | Cancer chemotherapy and pharmacology 20110701 |
| In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites. | Amino acids 20110701 |
| Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells. | Experimental hematology 20110701 |
| Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols. | Leukemia & lymphoma 20110701 |
| Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study. | Cancer science 20110701 |
| SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. | Molecular cancer research : MCR 20110701 |
| Assay for determination of daunorubicin in cancer cells with multidrug resistance phenotype. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110701 |
| A pH-responsive cleavage route based on a metal-organic coordination bond. | Chemistry (Weinheim an der Bergstrasse, Germany) 20110620 |
| Binding assay for cholera toxin based on sequestration electrochemistry using lactose labeled with an electroactive compound. | The Analyst 20110607 |
| The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study). | Leukemia research 20110601 |
| Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy. | Leukemia research 20110601 |
| Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis. | Clinical and experimental nephrology 20110601 |
| Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience. | Japanese journal of clinical oncology 20110601 |
| Myeloid sarcoma in a child with acute myeloblastic leukaemia. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20110601 |
| Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2. | Journal of medicinal chemistry 20110512 |
| In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity. | Archives of toxicology 20110501 |
| MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. | Haematologica 20110501 |
| Proteomic insights into chronic anthracycline cardiotoxicity. | Journal of molecular and cellular cardiology 20110501 |
| Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. | Leukemia 20110501 |
| Daunorubicin does not induce immunohistochemically detectable endothelial dysfunction in rabbit aorta and femoral artery. | Histology and histopathology 20110501 |
| Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China. | International journal of hematology 20110501 |
| Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart. | Cardiovascular research 20110401 |
| [Plasmacytoid dendritic cell tumor]. | Actas dermo-sifiliograficas 20110401 |
| Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood. | Pediatric blood & cancer 20110401 |
| Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells. | Oncology reports 20110401 |
| Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China. | International journal of hematology 20110401 |
| Interaction of aristololactam-β-D-glucoside and daunomycin with poly(A): spectroscopic and calorimetric studies. | Biophysical chemistry 20110401 |
| Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC. | The Journal of antimicrobial chemotherapy 20110401 |
| Changes in lognormal shape parameter guide design of patient-specific radiochemotherapy cocktails. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110401 |
| [Effect of magnetic nanoparticle of Fe3O4 combined with daunorubicin on lymphoma cell line Raji]. | Zhongguo shi yan xue ye xue za zhi 20110401 |
| Granulocytic sarcoma of palate. Case report and review of literature. | The New York state dental journal 20110401 |
| Beau's lines. | The Journal of the Association of Physicians of India 20110401 |
| Stability of epidoxorubicin in solid state. | Journal of pharmaceutical and biomedical analysis 20110325 |
| First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310 |
| Blood consult: acute myeloid leukemia and the t(8;21)(q22;22). | Blood 20110310 |
| APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells. | European journal of haematology 20110301 |
| Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. | Biomaterials 20110301 |
| The role of standard-dose cytarabine in children with acute promyelocytic leukemia: a single-center experience. | Journal of pediatric hematology/oncology 20110301 |
| [Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells. | Leukemia research 20110301 |
| Inhibition of unwinding and ATPase activities of pea MCM6 DNA helicase by actinomycin and nogalamycin. | Plant signaling & behavior 20110301 |
| [Effect of daunorubicin and rapamycin combination on the proliferation of acute leukemia cells]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110301 |
| Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. | Blood 20110224 |
| Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer. | Molecular pharmaceutics 20110207 |
| Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides. | Molecular pharmaceutics 20110207 |
| Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110201 |
| [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells]. | Zhongguo shi yan xue ye xue za zhi 20110201 |
| [Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line]. | Zhongguo shi yan xue ye xue za zhi 20110201 |
| Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. | FEBS letters 20110121 |
| Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells. | Blood 20110113 |
| Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions. | Toxicology 20110111 |
| Efficient synthesis of an (aminooxy) acetylated-somatostatin derivative using (aminooxy)acetic acid as a 'carbonyl capture' reagent. | Journal of peptide science : an official publication of the European Peptide Society 20110101 |
| Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity. | Current medicinal chemistry 20110101 |
| Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells. | Hematology (Amsterdam, Netherlands) 20110101 |
| Pharmacokinetics and tissue distribution of dual-targeting daunorubicin liposomes in mice. | Pharmacology 20110101 |
| Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia. | Pharmacological reports : PR 20110101 |
| [Energetics of complex formation of the DNA hairpin structure d(GCGAAGC) with aromatic ligands]. | Biofizika 20110101 |
| Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. | International journal of nanomedicine 20110101 |
| Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions. | Nutrition and cancer 20110101 |
| Structuring detergents for extracting and stabilizing functional membrane proteins. | PloS one 20110101 |
| Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. | Journal of translational medicine 20110101 |
| Copy number polymorphisms and anticancer pharmacogenomics. | Genome biology 20110101 |
| P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA. | BMC cancer 20110101 |
| Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. | International journal of nanomedicine 20110101 |
| Targeting RNA by small molecules: comparative structural and thermodynamic aspects of aristololactam-β-D-glucoside and daunomycin binding to tRNA(phe). | PloS one 20110101 |
| Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells. | Journal of experimental & clinical cancer research : CR 20110101 |
| Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells. | PloS one 20110101 |
| A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy. | PloS one 20110101 |
| A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. | International journal of nanomedicine 20110101 |
| Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. | PloS one 20110101 |
| Mitochondrial mode of action of a thymidine-based cisplatin analogue breaks resistance in cancer cells. | Chemistry (Weinheim an der Bergstrasse, Germany) 20101227 |
| Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101223 |
| BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. | Blood 20101216 |
| Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. | Blood 20101216 |
| Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. | Lancet (London, England) 20101211 |
| A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia. | Leukemia research 20101201 |
| An unusual case of acute myeloid leukemia: late isolated testicular relapse followed by isolated central nervous system relapse. | Pediatric blood & cancer 20101201 |
| Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia. | Drug metabolism letters 20101201 |
| Triggering liposomal drug release with a lysosomotropic agent. | Journal of pharmaceutical sciences 20101201 |
| Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. | Experimental hematology 20101201 |
| Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. | The Journal of pharmacology and experimental therapeutics 20101201 |
| Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release. | Thrombosis and haemostasis 20101201 |
| Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats. | The Journal of pharmacy and pharmacology 20101201 |
| [Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20101201 |
| Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. | Blood 20101118 |
| Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study. | Cancer 20101115 |
| Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. | Blood 20101111 |
| The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. | Blood 20101104 |
| Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays. | Cytotherapy 20101101 |
| Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8. | Japanese journal of clinical oncology 20101101 |
| Questions regarding frontline therapy of acute myeloid leukemia. | Cancer 20101101 |
| Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. | Free radical research 20101101 |
| Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines. | Bioorganic & medicinal chemistry letters 20101101 |
| Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience. | Journal of pediatric hematology/oncology 20101101 |
| Synthesis and biological properties of oxazolinodaunorubicin--a new derivative of daunorubicin with a modified daunosamine moiety. | Investigational new drugs 20101001 |
| Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors. | Leukemia research 20101001 |
| Synergistic electrochemotherapy on cancer cells by photodynamically active cytostatic agents. | Bioelectrochemistry (Amsterdam, Netherlands) 20101001 |
| Electroporation and alternating current cause membrane permeation of photodynamic cytotoxins yielding necrosis and apoptosis of cancer cells. | Bioelectrochemistry (Amsterdam, Netherlands) 20101001 |
| Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen. | Cancer 20101001 |
| MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. | The Prostate 20101001 |
| Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association? | American journal of hematology 20101001 |
| Treatment of pediatric Burkitt lymphoma in Turkey. | Journal of pediatric hematology/oncology 20101001 |
| Acute myeloid leukemia associated with t(10;17)(p13-15;q12-21) and phagocytic activity by leukemic blasts: a clinical study and review of the literature. | Cancer genetics and cytogenetics 20101001 |
| Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia? | American journal of hematology 20101001 |
| CRIM1 is expressed at higher levels in drug-resistant than in drug-sensitive myeloid leukemia HL60 cells. | Anticancer research 20101001 |
| P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. | Blood 20100902 |
| Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts. | Leukemia research 20100901 |
| The serine/threonine protein phosphatase Sit4p activates multidrug resistance in Saccharomyces cerevisiae. | FEMS yeast research 20100901 |
| Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission. | Leukemia & lymphoma 20100901 |
| [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20100901 |
| [The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20100901 |
| A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial. | Blood 20100812 |
| Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia. | Journal of pediatric hematology/oncology 20100801 |
| Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts. | Leukemia & lymphoma 20100801 |
| Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia. | Pediatric blood & cancer 20100801 |
| Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma. | Hepatology (Baltimore, Md.) 20100801 |
| [Effect of cisplatin, topotecan, daunorubicin and hydroxyurea on human mesenchymal stem cells]. | Zhongguo shi yan xue ye xue za zhi 20100801 |
| [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype]. | The Korean journal of laboratory medicine 20100801 |
| Simultaneous determination of cytosine arabinoside, daunorubicin and etoposide in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100715 |
| Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin. | Leukemia research 20100701 |
| Overexpression of aveBIV leading to the improvement of 4'-epidaunorubicin production in Streptomyces coeruleorubidus strain SIPI-A0707. | Applied microbiology and biotechnology 20100701 |
| Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial. | Leukemia 20100701 |
| Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia. | Journal of medical virology 20100701 |
| Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance. | Anticancer research 20100701 |
| Effect of altered temperature storage on the in vitro cellular uptake of liposome drug products. | Journal of liposome research 20100601 |
| Effects of Curcuma spp. on P-glycoprotein function. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20100601 |
| Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment. | Japanese journal of clinical oncology 20100601 |
| Differences in accumulation of anthracyclines daunorubicin, doxorubicin and epirubicin in rat tissues revealed by immunocytochemistry. | Histochemistry and cell biology 20100601 |
| Simultaneous determination of anthracyclines and taxanes in human serum using online sample extraction coupled to high performance liquid chromatography with UV detection. | Journal of separation science 20100601 |
| Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. | The Lancet. Oncology 20100601 |
| Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution. | Leukemia & lymphoma 20100601 |
| Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas. | Leukemia & lymphoma 20100601 |
| Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line. | Leukemia & lymphoma 20100601 |
| Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line. | Chinese journal of cancer 20100601 |
| Can a blood test monitor lymphoma? | Leukemia & lymphoma 20100601 |
| [Effect of sorafenib combined with daunorubicin on K562 cell line]. | Zhongguo shi yan xue ye xue za zhi 20100601 |
| Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin. | International journal of pharmaceutics 20100531 |
| Design, synthesis and evaluation of progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux. | Bioorganic & medicinal chemistry letters 20100515 |
| Interaction of an anthracycline disaccharide with ctDNA: Investigation by spectroscopic technique and modeling studies. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100501 |
| Increased affinity to canalicular P-gp via formation of lipophilic ion-pair complexes with endogenous bile salts is associated with mw threshold in hepatobiliary excretion of quaternary ammonium compounds. | Pharmaceutical research 20100501 |
| Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. | American journal of hematology 20100501 |
| Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy. | Pediatric hematology and oncology 20100501 |
| [Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100501 |
| Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. | Leukemia research 20100401 |
| Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status. | Leukemia research 20100401 |
| Central nervous system involvement at the time of presentation in acute promyelocytic leukemia. | Pediatric blood & cancer 20100401 |
| Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma. | Pediatric blood & cancer 20100401 |
| Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. | British journal of haematology 20100401 |
| Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia. | Journal of thrombosis and haemostasis : JTH 20100401 |
| Increased interaction between DJ-1 and the Mi-2/ nucleosome remodelling and deacetylase complex during cellular stress. | Proteomics 20100401 |
| Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis. | The Journal of biological chemistry 20100305 |
| Dermatomyositis associated with acute myelocytic leukemia. | Rheumatology international 20100301 |
| Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. | Cancer investigation 20100301 |
| Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. | Pharmacological research 20100301 |
| Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism. | The Journal of pharmacology and experimental therapeutics 20100301 |
| Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience. | American journal of hematology 20100301 |
| Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction. | Journal of pediatric hematology/oncology 20100301 |
| Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells. | International journal of molecular medicine 20100301 |
| Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma. | Chinese journal of cancer 20100301 |
| Heart transplant in a childhood leukemia survivor: a case report. | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20100301 |
| Mees lines and Beau lines after chemotherapy. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20100223 |
| Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220 |
| Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210 |
| Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. | Molecules (Basel, Switzerland) 20100209 |
| The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. | Blood 20100204 |
| Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG). | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100201 |
| Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells. | Thrombosis research 20100201 |
| [High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]. | Bulletin du cancer 20100201 |
| [Acute lower limb ischemia revealing acute leukemia. Case report and review of the literature]. | Journal des maladies vasculaires 20100201 |
| 'I am older, not elderly,' said the patient with acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201 |
| Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201 |
| Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury. | Pediatric hematology and oncology 20100201 |
| [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02]. | Zhongguo shi yan xue ye xue za zhi 20100201 |
| [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors]. | Zhongguo shi yan xue ye xue za zhi 20100201 |
| Updates on the treatment of acute promyelocytic leukemia. | Clinical advances in hematology & oncology : H&O 20100201 |
| Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. | Journal of controlled release : official journal of the Controlled Release Society 20100125 |
| Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo. | Journal of pharmaceutical sciences 20100101 |
| Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group. | British journal of haematology 20100101 |
| Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia. | British journal of haematology 20100101 |
| Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements. | British journal of haematology 20100101 |
| Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20100101 |
| Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139. | Anticancer research 20100101 |
| [Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7]. | Vnitrni lekarstvi 20100101 |
| Therapy of acute myelogenous leukemia in adults. | Cancer treatment and research 20100101 |
| Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits. | Physiological research 20100101 |
| Effect of naringin on the DNA damage induced by daunorubicin in mouse hepatocytes and cardiocytes. | Biological & pharmaceutical bulletin 20100101 |
| Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats. | Toxicology 20100101 |
| A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2. | Acta haematologica 20100101 |
| Antiproliferative and pro-apoptotic effects of quercetin on human pancreatic carcinoma cell lines EPP85-181P and EPP85-181RDB. | Folia histochemica et cytobiologica 20100101 |
| Adhesion-induced drug resistance in leukemia stem cells. | Pharmacology 20100101 |
| Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101 |
| Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells. | International journal of nanomedicine 20100101 |
| Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes. | Marine drugs 20100101 |
| Puffiness of the eyelids and lips with multiple subcutaneous masses in 2-month-old infant. | Hematology/oncology and stem cell therapy 20100101 |
| Antigenotoxic effect of Chamomilla recutita (L.) Rauschert essential oil in mouse spermatogonial cells, and determination of its antioxidant capacity in vitro. | International journal of molecular sciences 20100101 |
| Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies. | International journal of nanomedicine 20100101 |
| Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells. | International journal of nanomedicine 20100101 |
| [Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified 'New York' protocols (1987-2003)]. | Przeglad lekarski 20100101 |
| Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients. | Pediatric blood & cancer 20091215 |
| Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961. | Pediatric blood & cancer 20091215 |
| Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129. | Pediatric blood & cancer 20091201 |
| Uptake of anthracyclines in vitro and in vivo in acute myeloid leukemia cells in relation to apoptosis and clinical response. | European journal of clinical pharmacology 20091201 |
| Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia. | American journal of hematology 20091201 |
| Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C. | Oncology reports 20091201 |
| Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia. | Journal of pediatric hematology/oncology 20091201 |
| Combined effects of bortezomib and daunorubicin on multiple myeloma cell KM3 in vitro. | Zhongguo shi yan xue ye xue za zhi 20091201 |
| A Rho-kinase inhibitor, fasudil, attenuates progressive glomerulosclerosis induced by daunorubicin in rats. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20091201 |
| Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy. | The Malaysian journal of pathology 20091201 |
| An integrative approach for the isolation, screening and analysis of antitumor agents by liquid chromatography combined with mass spectrometry. | Analytica chimica acta 20091123 |
| A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. | Immunity 20091120 |
| Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110 |
| A comparison of the stability of doxorubicin and daunorubicin in solid state. | Journal of pharmaceutical and biomedical analysis 20091101 |
| Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. | Annals of hematology 20091101 |
| Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity. | Bioorganic & medicinal chemistry letters 20091101 |
| The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro. | Anticancer research 20091101 |
| Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer. | Biochemical and biophysical research communications 20091030 |
| A novel protein that binds to dnrN-dnrO intergenic region of Streptomyces peucetius purified by DNA affinity capture has dihydrolipoamide dehydrogenase activity. | Protein expression and purification 20091001 |
| Daunorubicin and doxorubicin inhibit the [(11)C]choline accumulation in cancer cells. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20091001 |
| Detection of submicroscopic disease in the bone marrow and unaffected testis of a child with T-cell acute lymphoblastic leukemia who experienced 'isolated' testicular relapse. | International journal of hematology 20091001 |
| [Effect of tetrandrine combined with daunorubicin on expressions of P21 and P-gp in K562/A02 cells]. | Zhongguo shi yan xue ye xue za zhi 20091001 |
| Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells. | Anticancer research 20091001 |
| [Standard therapies for acute myeloid leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20091001 |
| High-dose daunorubicin in older patients with acute myeloid leukemia. | The New England journal of medicine 20090924 |
| Anthracycline dose intensification in acute myeloid leukemia. | The New England journal of medicine 20090924 |
| Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090901 |
| siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53. | Leukemia research 20090901 |
| The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin. | Cell cycle (Georgetown, Tex.) 20090815 |
| Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. | Blood 20090813 |
| A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. | Leukemia research 20090801 |
| Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia. | Leukemia research 20090801 |
| Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial. | Leukemia 20090801 |
| Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin. | Leukemia research 20090801 |
| Laromustine: the return of alkylators to non-myeloablative therapy of AML. | Leukemia research 20090801 |
| Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization. | Nature neuroscience 20090801 |
| Inactivating the activated: identifying functions of specific neural networks. | Nature neuroscience 20090801 |
| [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801 |
| Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse. | Journal of pharmaceutical sciences 20090701 |
| Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines. | Annals of hematology 20090701 |
| Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. | The Journal of pediatrics 20090701 |
| Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. | American journal of hematology 20090701 |
| [Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection]. | Ai zheng = Aizheng = Chinese journal of cancer 20090701 |
| Treating childhood acute lymphoblastic leukemia without cranial irradiation. | The New England journal of medicine 20090625 |
| The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution. | European journal of pharmacology 20090624 |
| Modeling the entropic structural transition of DNA complexes formed with intercalating drugs. | Physical biology 20090612 |
| Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus on daunorubicin cardiotoxicity. | Phytotherapy research : PTR 20090601 |
| Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. | Leukemia 20090601 |
| Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. | British journal of haematology 20090601 |
| DNA damage response as a biomarker in treatment of leukemias. | Cell cycle (Georgetown, Tex.) 20090601 |
| A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint. | Genes & development 20090601 |
| Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. | Puerto Rico health sciences journal 20090601 |
| Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy. | Chinese journal of integrative medicine 20090601 |
| Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. | Journal of pediatric hematology/oncology 20090601 |
| Mapping daunorubicin-binding Sites in the ATP-binding cassette transporter MsbA using site-specific quenching by spin labels. | The Journal of biological chemistry 20090515 |
| The effect of cantharidins on leukemic stem cells. | International journal of cancer 20090501 |
| Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. | Drug metabolism and disposition: the biological fate of chemicals 20090501 |
| Acute myelogenous leukemia presenting as acute infectious meningitis in a 7-year-old boy. | Clinical pediatrics 20090501 |
| The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial. | British journal of haematology 20090501 |
| Fibrates in the chemical action of daunorubicin. | Current cancer drug targets 20090501 |
| The ABC transporter MsbA interacts with lipid A and amphipathic drugs at different sites. | The Biochemical journal 20090415 |
| Mucoepidermoid carcinoma of the submandibular gland after chemotherapy in a child. | Auris, nasus, larynx 20090401 |
| The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds. | Cancer chemotherapy and pharmacology 20090401 |
| Potent modulation of P-glycoprotein activity by naturally occurring phenylbutenoids from Zingiber cassumunar. | Phytotherapy research : PTR 20090401 |
| Chemotherapy induced esophageal stricture. | Pediatric blood & cancer 20090401 |
| A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over. | Leukemia 20090401 |
| Study on the enhanced cellular uptake effect of daunorubicin on leukemia cells mediated via functionalized nickel nanoparticles. | Biomedical materials (Bristol, England) 20090401 |
| Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia. | Leukemia 20090301 |
| Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. | Blood 20090226 |
| Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. | Annals of hematology 20090201 |
| Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde. | Bioelectrochemistry (Amsterdam, Netherlands) 20090201 |
| Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. | Ai zheng = Aizheng = Chinese journal of cancer 20090201 |
| Structure of the transcriptional regulator LmrR and its mechanism of multidrug recognition. | The EMBO journal 20090121 |
| In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. | Leukemia research 20090101 |
| Effect of flavonoids on daunorubicin-induced toxicity in H9c2 Cardiomyoblasts. | Phytotherapy research : PTR 20090101 |
| Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla. | Fitoterapia 20090101 |
| A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene. | Blood cells, molecules & diseases 20090101 |
| Imatinib is a substrate for various multidrug resistance proteins. | Neoplasma 20090101 |
| HIV-associated multicentric Castleman disease. | Current opinion in HIV and AIDS 20090101 |
| Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells. | International journal of nanomedicine 20090101 |
| Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. | International journal of nanomedicine 20090101 |
| Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin. | Biochimica et biophysica acta 20090101 |
| Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. | Oncology research 20090101 |
| Plasma cardiac necrosis markers C-troponin I and creatine kinase, associated with increased malondialdehyde levels, induced in rabbits by means of 5-aminolevulinic acid injection. | Pharmacology 20090101 |
| Testicular function after treatment for acute lymphoblastic leukemia (all) in prepubertal and pubertal boys. | Pediatric hematology and oncology 20090101 |
| Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. | Journal of neuroinflammation 20090101 |
| Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy. | PloS one 20090101 |
| Zygomycosis in a 13 year old girl with T-NHL. | Klinische Padiatrie 20090101 |
| Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo. | International journal of nanomedicine 20090101 |
| Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells. | International journal of nanomedicine 20090101 |
| Optimal induction and post-remission therapy for AML in first remission. | Hematology. American Society of Hematology. Education Program 20090101 |
| Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature. | In vivo (Athens, Greece) 20090101 |
| Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. | European journal of pharmacology 20081214 |
| Recurrent episodes of fever and pancytopenia due to haemophagocytosis during maintenance therapy for acute myeloid leukaemia. | British journal of haematology 20081201 |
| Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia. | Leukemia 20081201 |
| Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. | Haematologica 20081201 |
| Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia. | British journal of haematology 20081201 |
| Licoflavone C attenuates the genotoxicity of cancer drugs in human peripheral lymphocytes. | Phytotherapy research : PTR 20081201 |
| Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia. | Cancer genetics and cytogenetics 20081201 |
| Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. | Leukemia & lymphoma 20081201 |
| CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. | Blood 20081115 |
| CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor). | Dermatology online journal 20081115 |
| The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia. | Leukemia research 20081101 |
| Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations. | Biomedical chromatography : BMC 20081101 |
| Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. | Oral diseases 20081101 |
| Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia. | International journal of hematology 20081101 |
| Existing and emerging therapeutic options for the treatment of acute myeloid leukemia. | Clinical advances in hematology & oncology : H&O 20081101 |
| Future research directions for the treatment of AML. | Clinical advances in hematology & oncology : H&O 20081101 |
| [Effects of survivin antisense oligodeoxynucleotide on drug resistance in K562 cells]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20081101 |
| Hydration of drug-DNA complexes: greater water uptake for adriamycin compared to daunomycin. | Journal of medicinal chemistry 20081009 |
| Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. | Cancer chemotherapy and pharmacology 20081001 |
| Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001 |
| Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001 |
| Direct determination of intracellular daunorubicin in intact confluent monolayers of AT1 prostate carcinoma cells using a multiwell-multilabel counter. | Analytical biochemistry 20081001 |
| Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors. | The Journal of pharmacy and pharmacology 20081001 |
| Diffuse large B-cell lymphoma. | Hematology/oncology clinics of North America 20081001 |
| Effect of surface chemistry modification of functional gold nanoparticles on the drug accumulation of cancer cells. | Journal of biomedical materials research. Part A 20080915 |
| Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. | Cancer 20080915 |
| Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. | Annals of hematology 20080901 |
| Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. | British journal of pharmacology 20080901 |
| Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan. | International journal of hematology 20080901 |
| Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2? | The FEBS journal 20080901 |
| Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation. | Rapid communications in mass spectrometry : RCM 20080901 |
| Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells. | International journal of nanomedicine 20080901 |
| Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine. | Journal of clinical pharmacology 20080801 |
| Flavonoids as inhibitors of human carbonyl reductase 1. | Chemico-biological interactions 20080730 |
| Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo. | The Journal of pharmacology and experimental therapeutics 20080701 |
| Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER). | Pharmaceutical research 20080701 |
| Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia. | Journal of pediatric hematology/oncology 20080701 |
| Two cases of post-liver transplant acute myeloid leukemia in Korean adults: review of bibliographies and comparison with post-renal transplant acute myeloid leukemia. | Annals of hematology 20080601 |
| Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro. | Drug metabolism and disposition: the biological fate of chemicals 20080601 |
| Structural elucidation of 4'-epiadriamycin by nuclear magnetic resonance spectroscopy and comparison with adriamycin and daunomycin using quantum mechanical and restrained molecular dynamics approach. | Archives of biochemistry and biophysics 20080601 |
| Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. | Leukemia 20080601 |
| Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations. | Leukemia 20080601 |
| A rare case of co-existent aggressive natural killer cell and acute monocytic leukemia with cytomegalovirus infection. | International journal of hematology 20080601 |
| CE-LIF method for the separation of anthracyclines: application to protein binding analysis in plasma using ultrafiltration. | Journal of separation science 20080601 |
| CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo. | Oncology reports 20080601 |
| [Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children]. | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20080601 |
| Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study. | Annals of hematology 20080501 |
| Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin. | Drug metabolism and disposition: the biological fate of chemicals 20080501 |
| Mutated and non-mutated TP53 as targets in the treatment of leukaemia. | British journal of haematology 20080501 |
| Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC). | Journal of separation science 20080501 |
| Genetic variants contributing to daunorubicin-induced cytotoxicity. | Cancer research 20080501 |
| A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma. | Leukemia & lymphoma 20080501 |
| A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma. | The Journal of steroid biochemistry and molecular biology 20080501 |
| Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers. | European journal of pharmacology 20080428 |
| Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410 |
| Granulocytic sarcoma with massive scalp involvement. | American journal of hematology 20080401 |
| Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia. | American journal of hematology 20080401 |
| MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. | Experimental hematology 20080401 |
| Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells. | International journal of hematology 20080401 |
| In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. | Haematologica 20080401 |
| Difficulty of peripheral blood stem cell collection after multiple consolidation therapy in acute myeloid leukemia. | Journal of clinical and experimental hematopathology : JCEH 20080401 |
| Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia. | Journal of Korean medical science 20080401 |
| Novel nanocomposite of nano fe(3)o(4) and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells. | Langmuir : the ACS journal of surfaces and colloids 20080304 |
| Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia. | Pediatric blood & cancer 20080301 |
| Acute myelogenous leukemia associated with Ollier disease. | Pediatric blood & cancer 20080301 |
| Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis. | Leukemia research 20080301 |
| The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia. | American journal of hematology 20080301 |
| Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking. | Molecular pharmacology 20080301 |
| The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy. | Leukemia 20080301 |
| Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death. | Blood 20080301 |
| Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. | Leukemia & lymphoma 20080301 |
| Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype. | Leukemia & lymphoma 20080301 |
| High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent. | Journal of biomolecular screening 20080301 |
| Flurazepam inhibits the P-glycoprotein transport function: an insight to revert multidrug-resistance phenotype. | European journal of pharmacology 20080226 |
| The interaction of DNR and glutaraldehyde with cell membrane proteins leads to morphological changes in erythrocytes. | Cancer letters 20080218 |
| Images in haematology. Bilateral adrenal chloromas. | British journal of haematology 20080201 |
| Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. | European journal of cancer (Oxford, England : 1990) 20080201 |
| Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080120 |
| Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110 |
| The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts. | Cellular & molecular biology letters 20080101 |
| Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma. | Haematologica 20080101 |
| Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity. | Hemoglobin 20080101 |
| [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20080101 |
| Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols. | Pediatric hematology and oncology 20080101 |
| Clustering of endocytic organelles in parental and drug-resistant myeloid leukaemia cell lines lacking centrosomally organised microtubule arrays. | The international journal of biochemistry & cell biology 20080101 |
| Anticancer effects of Annona glabra plant extracts in human leukemia cell lines. | Anticancer research 20080101 |
| Relapse of acute myeloid leukemia as isolated bilateral testicular granulocytic sarcoma in an adult. | Urology journal 20080101 |
| Selective inhibition of yeast regulons by daunorubicin: a transcriptome-wide analysis. | BMC genomics 20080101 |
| [Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I]. | Bioorganicheskaia khimiia 20080101 |
| Effect of zinc and copper on the interaction of daunorubicin with cardiac myosin. | Biological trace element research 20080101 |
| [Efficacy of conservative treatment of gastric lymphosarcoma]. | Terapevticheskii arkhiv 20080101 |
| [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas]. | Terapevticheskii arkhiv 20080101 |
| [Intensive chemotherapy of diffuse large B-cell lymphosarcoma in a female patient with chronic renal failure and afunctional left kidney]. | Terapevticheskii arkhiv 20080101 |
| Curative strategies in acute promyelocytic leukemia. | Hematology. American Society of Hematology. Education Program 20080101 |
| Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells. | Acta biochimica Polonica 20080101 |
| [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience]. | Medycyna wieku rozwojowego 20080101 |
| [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl]. | Medycyna wieku rozwojowego 20080101 |
| [Acute pancreatitis during chemotherapy of acute lymphoblastic leukaemia complicated with pseudocyst]. | Medycyna wieku rozwojowego 20080101 |
| Dissecting the component reactions catalyzed by the actinorhodin minimal polyketide synthase. | Biochemistry 20071218 |
| In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. | Journal of controlled release : official journal of the Controlled Release Society 20071204 |
| Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). | American journal of hematology 20071201 |
| Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane. | The FEBS journal 20071201 |
| Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071201 |
| Edaravone, a potent free radical scavenger, prevents anthracycline-induced myocardial cell death. | Circulation journal : official journal of the Japanese Circulation Society 20071101 |
| Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. | Haematologica 20071101 |
| The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group. | Haematologica 20071101 |
| [A short duration treatment with intensive consolidation therapy for patients with acute myelogenous leukemia--13 year experience in a single institute]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071101 |
| Predicting asparaginase-associated pancreatitis. | Pediatric blood & cancer 20071015 |
| Daunomycin binding to detergent micelles: a model system for evaluating the hydrophobic contribution to drug-DNA interactions. | The journal of physical chemistry. B 20071004 |
| Trisomy 21 as a sole acquired abnormality in an adult Omani patient with CD7- and CD9-positive acute myeloid leukemia. | Archives of medical research 20071001 |
| Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples. | British journal of haematology 20071001 |
| Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia. | Therapeutic drug monitoring 20071001 |
| Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line. | Biochemistry and cell biology = Biochimie et biologie cellulaire 20071001 |
| Inhibitory effects of ginsenosides and their hydrolyzed metabolites on daunorubicin transport in KB-C2 cells. | Biological & pharmaceutical bulletin 20071001 |
| Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes. | Cancer letters 20070918 |
| AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. | Blood 20070915 |
| Transition on the entropic elasticity of DNA induced by intercalating molecules. | The Journal of chemical physics 20070914 |
| All-trans retinoic acid syndrome: another cause of drug-induced respiratory failure. | Southern medical journal 20070901 |
| Liposomal daunorubicin as treatment for Kaposi's sarcoma. | International journal of nanomedicine 20070901 |
| Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia. | Pediatric blood & cancer 20070801 |
| On the origin of the decrease in stability of the DNA hairpin d(GCGAAGC) on complexation with aromatic drugs. | Biophysical chemistry 20070801 |
| Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia. | Journal of clinical pharmacology 20070801 |
| The criteria for bone marrow recovery post-myelosuppressive therapy for acute myelogenous leukemia: a quantitative study. | Archives of pathology & laboratory medicine 20070801 |
| In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. | Toxicology 20070731 |
| Analytical method for beta-amyloid fibrils using CE-laser induced fluorescence and its application to screening for inhibitors of beta-amyloid protein aggregation. | Analytical chemistry 20070701 |
| Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia. | International journal of oncology 20070701 |
| Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma. | European journal of neurology 20070701 |
| Inhibition of P-glycoprotein function by tannic acid and pentagalloylglucose. | The Journal of pharmacy and pharmacology 20070701 |
| Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH). | Toxicology 20070625 |
| Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial. | Blood 20070615 |
| Species differences of inhibitory effects on P-glycoprotein-mediated drug transport. | Journal of pharmaceutical sciences 20070601 |
| Improved immunocytochemical detection of daunomycin. | Histochemistry and cell biology 20070601 |
| Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. | Phytotherapy research : PTR 20070601 |
| A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity. | Drug metabolism and disposition: the biological fate of chemicals 20070601 |
| Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia. | British journal of haematology 20070601 |
| The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors. | Leukemia 20070601 |
| Mapping genes that contribute to daunorubicin-induced cytotoxicity. | Cancer research 20070601 |
| Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting. | Leukemia & lymphoma 20070601 |
| Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. | Pediatric hematology and oncology 20070601 |
| Isolated granulocytic sarcoma of the orbit. | European journal of haematology 20070501 |
| Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow. | Haematologica 20070501 |
| [Effects of daunorubicin on the expression of brain natriuretic peptide gene in myocardial cells: an in vitro experiment with cultured myocardial cells from rats]. | Zhonghua yi xue za zhi 20070424 |
| Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-. | Journal of medicinal chemistry 20070419 |
| Mechanisms of ischemic stroke in HIV-infected patients. | Neurology 20070417 |
| Chemotherapy exposure increases leukemia cell stiffness. | Blood 20070415 |
| Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues. | The Journal of organic chemistry 20070413 |
| Traces of phosgene in chloroform: consequences for extraction of anthracyclines. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401 |
| Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. | American journal of physiology. Cell physiology 20070401 |
| Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. | Blood 20070401 |
| Interactions of cyclosporin a with breast cancer resistance protein. | Drug metabolism and disposition: the biological fate of chemicals 20070401 |
| IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells. | Laboratory investigation; a journal of technical methods and pathology 20070401 |
| Acute cardiac functional and morphological changes after Anthracycline infusions in children. | The American journal of cardiology 20070401 |
| Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: prognostic implications. | Hematology (Amsterdam, Netherlands) 20070401 |
| Diffuse alveolar damage and hemorrhage in acute myelogenous leukemia treated with corticosteroids. | Connecticut medicine 20070401 |
| [Effect of daunorubicin and cytarabine on cell line NB4]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20070401 |
| Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia. | The Korean journal of laboratory medicine 20070401 |
| Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways. | British journal of cancer 20070326 |
| The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance. | Journal of biomedical materials research. Part A 20070315 |
| T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia. | Pediatric blood & cancer 20070301 |
| Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. | Pediatric blood & cancer 20070301 |
| Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol. | Pediatric blood & cancer 20070301 |
| Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. | Cancer chemotherapy and pharmacology 20070301 |
| The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells. | ChemMedChem 20070301 |
| Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group. | Leukemia 20070301 |
| Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. | Haematologica 20070301 |
| Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. | Haematologica 20070301 |
| Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay. | PLoS genetics 20070301 |
| Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. | Pediatric hematology and oncology 20070301 |
| Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1. | Cancer letters 20070208 |
| Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. | Oncogene 20070208 |
| Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. | European journal of haematology 20070201 |
| Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070201 |
| Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias. | Hematology (Amsterdam, Netherlands) 20070201 |
| Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties. | Cancer chemotherapy and pharmacology 20070101 |
| Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. | Chemosphere 20070101 |
| Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies. | Histochemistry and cell biology 20070101 |
| Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. | Journal of pharmaceutical sciences 20070101 |
| Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria. | Apoptosis : an international journal on programmed cell death 20070101 |
| Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. | The Journal of pathology 20070101 |
| Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination. | Physiological research 20070101 |
| Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. | Molecular pharmaceutics 20070101 |
| [The effect of rubomycin, mexidol and emoxypine on some metabolic indexes and the proccess of spontaneous metastasis under conditions of experimental neoplasia]. | Eksperimental'naia i klinicheskaia farmakologiia 20070101 |
| Biological properties of new derivatives of daunorubicin. | In vivo (Athens, Greece) 20070101 |
| LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. | Molecular cancer 20070101 |
| Selectivity of an indolyl berberine derivative for tetrameric G-quadruplex DNA. | Rapid communications in mass spectrometry : RCM 20070101 |
| Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells. | Molecular cancer 20070101 |
| Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents. | Physiological research 20070101 |
| Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia. | Klinische Padiatrie 20070101 |
| [Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070101 |
| Vascular endothelium: target or victim of cytostatic therapy? | Canadian journal of physiology and pharmacology 20070101 |
| [Comparison of the present and previously used protocol of risk stratification in children with acute lymphoblastic leukemia]. | Medycyna wieku rozwojowego 20070101 |
| Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment. | BioFactors (Oxford, England) 20070101 |
| Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs. | Advances in experimental medicine and biology 20070101 |
| [The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity]. | Terapevticheskii arkhiv 20070101 |
| Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. | Pathology oncology research : POR 20070101 |
| Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure. | Acta haematologica 20070101 |
| Altered pharmacokinetics of daunorubicin in rats with CCl4-induced hepatic injury. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20070101 |
| Neutropenic enterocolitis: is there a right timing for surgery? Assessment of a clinical case. | Tumori 20070101 |
| A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators. | Journal of medicinal chemistry 20061228 |
| Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061220 |
| Amrubicin induces apoptosis in human tumor cells mediated by the activation of caspase-3/7 preceding a loss of mitochondrial membrane potential. | Cancer science 20061201 |
| Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity. | The Journal of pharmacology and experimental therapeutics 20061201 |
| Complexation of anthracycline drugs with DNA in the presence of caffeine. | European biophysics journal : EBJ 20061201 |
| Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions. | Pediatric hematology and oncology 20061201 |
| Increased mortality with FLA compared with ADE chemotherapy in high-risk AML. | Blood 20061201 |
| Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats. | Basic & clinical pharmacology & toxicology 20061201 |
| seco-Cycloartane triterpenes from Gardenia aubryi. | Journal of natural products 20061201 |
| Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature. | Haematologica 20061201 |
| Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response. | Haematologica 20061201 |
| [Combined effect of recombinant mutant human TRAIL and daunorubicin in inducing apoptosis of leukemia cell and its mechanism]. | Zhongguo shi yan xue ye xue za zhi 20061201 |
| Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells. | Leukemia research 20061101 |
| Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol. | European journal of haematology 20061101 |
| Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter. | British journal of pharmacology 20061101 |
| Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. | Bioscience, biotechnology, and biochemistry 20061101 |
| Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism. | Cancer chemotherapy and pharmacology 20061001 |
| Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins. | European journal of haematology 20061001 |
| CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome. | Leukemia & lymphoma 20061001 |
| Improvement of intestinal absorption of P-glycoprotein substrate by D-tartaric acid. | Drug metabolism and pharmacokinetics 20061001 |
| Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920 |
| [Twenty years of treating childhood acute lymphoblastic leukemia]. | Anales de pediatria (Barcelona, Spain : 2003) 20060901 |
| AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective. | Leukemia & lymphoma 20060901 |
| Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy. | Current hematologic malignancy reports 20060901 |
| Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents. | European journal of medical research 20060830 |
| Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. | Blood 20060815 |
| Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines. | Biopolymers 20060805 |
| Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia. | Leukemia research 20060801 |
| Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. | Journal of cellular physiology 20060801 |
| [Acute monoblastic leukemia with tetrasomy 8]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060801 |
| In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. | International journal of cancer 20060715 |
| Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents. | Cancer research 20060715 |
| Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein. | Cancer chemotherapy and pharmacology 20060701 |
| 9-O-acetyl GD3 protects tumor cells from apoptosis. | International journal of cancer 20060701 |
| Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. | Molecular pharmacology 20060701 |
| Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. | The Annals of thoracic surgery 20060701 |
| Electrochemical detection and control of interactions between DNA and electroactive intercalator using a DNA-alginate complex film modified electrode. | Environmental science & technology 20060701 |
| Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer. | Molecular cancer therapeutics 20060701 |
| Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. | Molecular cancer therapeutics 20060701 |
| Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. | Anti-cancer drugs 20060701 |
| Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats. | International journal of cardiology 20060628 |
| [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]. | Ugeskrift for laeger 20060626 |
| Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. | Blood 20060615 |
| Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity. | Bioorganic & medicinal chemistry 20060615 |
| STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model. | Chinese medical journal 20060605 |
| Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia. | Cancer genetics and cytogenetics 20060601 |
| Heterologous expression of a mammalian ABC transporter in plant and its application to phytoremediation. | Plant molecular biology 20060601 |
| Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia. | The Malaysian journal of pathology 20060601 |
| Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Shifting to outpatient management of acute myeloid leukemia: a prospective experience. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes. | Cytometry. Part B, Clinical cytometry 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Changes in angiopoietin expression in glomeruli involved in glomerulosclerosis in rats with daunorubicin-induced nephrosis. | Acta pharmacologica Sinica 20060501 |
| Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells. | Cancer chemotherapy and pharmacology 20060401 |
| Investigation of genotoxic and antigenotoxic activities of Melampodium divaricatum in Salmonella typhimurium. | Toxicology in vitro : an international journal published in association with BIBRA 20060401 |
| Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. | Leukemia research 20060401 |
| Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. | Annals of oncology : official journal of the European Society for Medical Oncology 20060401 |
| Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. | Haematologica 20060401 |
| [Alteration of expression of survivin in HL-60 cells treated with chemotherapeutic drugs]. | Zhongguo shi yan xue ye xue za zhi 20060401 |
| Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia. | Journal of medicinal chemistry 20060309 |
| Immune thrombocytopenia following successful treatment of cancer in children. | Pediatric blood & cancer 20060301 |
| ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement. | Pediatric blood & cancer 20060301 |
| Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20060301 |
| Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. | Leukemia research 20060301 |
| Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. | British journal of haematology 20060301 |
| Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors. | International journal of oncology 20060301 |
| Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060301 |
| Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells. | Molecular cancer therapeutics 20060301 |
| Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. | Journal of medicinal chemistry 20060209 |
| Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity. | Phytotherapy research : PTR 20060201 |
| Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication. | Danish medical bulletin 20060201 |
| Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. | Cancer chemotherapy and pharmacology 20060101 |
| Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia. | Leukemia research 20060101 |
| Niemann-Pick C1 protein facilitates the efflux of the anticancer drug daunorubicin from cells according to a novel vesicle-mediated pathway. | The Journal of pharmacology and experimental therapeutics 20060101 |
| Structure of daunomycin complexed to d-TGATCA by two-dimensional nuclear magnetic resonance spectroscopy. | European journal of medicinal chemistry 20060101 |
| Effects of idarubicin and idarubicinol on rat coronary resistance and vasoconstrictor responsiveness of isolated aorta and mesentery. | Anti-cancer drugs 20060101 |
| Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. | Cell cycle (Georgetown, Tex.) 20060101 |
| Concomitant hairy cell and acute myeloid leukemia. | European journal of haematology 20060101 |
| Granulocytic sarcoma of the gingiva with trisomy 21. | American journal of hematology 20060101 |
| Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. | Molecular pharmaceutics 20060101 |
| Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes. | Anticancer research 20060101 |
| Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. | BMC cancer 20060101 |
| [Interaction between aromatic antibiotics and vitamins: 1H NMR analysis of the heteroassociation of nicotinamide and anthracycline antitumor antibiotics]. | Biofizika 20060101 |
| Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. | BMC cancer 20060101 |
| Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells. | Anticancer research 20060101 |
| [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. | Przeglad lekarski 20060101 |
| Zygomycosis in the immunocompromised patient: a case report. | Acta bio-medica : Atenei Parmensis 20060101 |
| Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia. | Acta bio-medica : Atenei Parmensis 20060101 |
| A potential pathological role of angiopoietins expression in glomeruli during progressive glomerulisclerosis related to podocyte injury. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101 |
| Reactions with dye free radicals reveal weak redox properties of drugs. | Photochemistry and photobiology 20060101 |
| Autoimmune hemolytic anemia as presenting manifestation of primary splenic anaplastic large cell lymphoma. | The Turkish journal of pediatrics 20060101 |
| [Reults of treatment with protocols BFM 90 and BFM 95]. | Medicinski arhiv 20060101 |
| [Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment]. | Przeglad lekarski 20060101 |
| A new bisintercalating anthracycline with picomolar DNA binding affinity. | Journal of medicinal chemistry 20051229 |
| A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study. | Cancer 20051215 |
| Multilayer microcapsules as anti-cancer drug delivery vehicle: deposition, Sustained release, and in vitro bioactivity. | Macromolecular bioscience 20051215 |
| Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. | Brain research 20051207 |
| Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. | The Journal of biological chemistry 20051202 |
| Syntheses and biological activities of daunorubicin analogs with uncommon sugars. | Bioorganic & medicinal chemistry 20051201 |
| Transepithelial transport of fluorescent p-glycoprotein and MRP2 substrates by insect Malpighian tubules: confocal microscopic analysis of secreted fluid droplets. | The Journal of experimental biology 20051201 |
| p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia. | Journal of pediatric hematology/oncology 20051201 |
| Acute leukaemia presenting as vulvar ulcers in an adolescent girl. | The Australian & New Zealand journal of obstetrics & gynaecology 20051201 |
| Idarubicin and idarubicinol effects on breast cancer multicellular spheroids. | Journal of chemotherapy (Florence, Italy) 20051201 |
| Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. | Oncogene 20051117 |
| Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. | Cancer 20051115 |
| Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. | Biochemical pharmacology 20051115 |
| Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis. | Oncogene 20051103 |
| Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients. | European journal of pediatrics 20051101 |
| Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. | Leukemia 20051101 |
| Characterization of cells with different mitochondrial membrane potential during apoptosis. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20051101 |
| Treatment of older patients with AML. | Critical reviews in oncology/hematology 20051101 |
| Mass spectrometry-based screening for inhibitors of beta-amyloid protein aggregation. | Analytical chemistry 20051101 |
| Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling. | Reproduction (Cambridge, England) 20051101 |
| Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation. | Haematologica 20051101 |
| Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation. | Haematologica 20051101 |
| The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis. | Blood 20051015 |
| Effects of alkyl gallates on P-glycoprotein function. | Biochemical pharmacology 20051015 |
| Chemotherapy dosing with elevated liver function test results in acute leukemia. | The Annals of pharmacotherapy 20051001 |
| Effects of new 4-aryl-1,4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein 1. | Journal of pharmaceutical sciences 20051001 |
| Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones. | Anti-cancer drugs 20051001 |
| Influence of initial charge state on fragmentation patterns for noncovalent drug/DNA duplex complexes. | Journal of mass spectrometry : JMS 20051001 |
| Inhibition study of rabbit liver cytosolic reductases involved in daunorubicin toxication. | Journal of enzyme inhibition and medicinal chemistry 20051001 |
| Effect of nonylphenol ethoxylates (NPEs) on barrier functions of epithelial cell membranes: opening of tight junctions and competitive inhibition of P-gp-mediated efflux. | International journal of pharmaceutics 20050930 |
| Schisandrin B--a novel inhibitor of P-glycoprotein. | Biochemical and biophysical research communications 20050923 |
| Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods. | Journal of pharmaceutical and biomedical analysis 20050915 |
| Engineered biosynthesis of aklanonic acid analogues. | Journal of the American Chemical Society 20050907 |
| Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. | Free radical biology & medicine 20050901 |
| 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients. | European journal of cancer (Oxford, England : 1990) 20050901 |
| Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. | Haematologica 20050901 |
| Could Candida dubliniensis be involved in lung fungus balls? | Revista iberoamericana de micologia 20050901 |
| Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Syntheses and biological activities of disaccharide daunorubicins. | Journal of medicinal chemistry 20050811 |
| Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study. | Cancer 20050801 |
| [Transfection of HL-60 cells with CYP3A5 gene induces drug-resistant phenotype]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050801 |
| DNA electrochemistry through the base pairs not the sugar-phosphate backbone. | Journal of the American Chemical Society 20050727 |
| Effects of peroxidase substrates on the Amplex red/peroxidase assay: antioxidant properties of anthracyclines. | Analytical biochemistry 20050715 |
| Inactivation of anthracyclines by cellular peroxidase. | Cancer research 20050715 |
| In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia. | Anti-cancer drugs 20050701 |
| Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls. | Leukemia & lymphoma 20050701 |
| Inhibition of P-glycoprotein by natural products in human breast cancer cells. | Archives of pharmacal research 20050701 |
| Reversion of human Pgp-dependent multidrug resistance by new sesquiterpenes from Zinowiewia costaricensis. | Journal of medicinal chemistry 20050630 |
| Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. | Chinese medical journal 20050605 |
| Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML). | Annals of hematology 20050601 |
| High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience. | Leukemia research 20050601 |
| [Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro]. | Zhongguo shi yan xue ye xue za zhi 20050601 |
| The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia. | Leukemia & lymphoma 20050601 |
| Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia. | Leukemia & lymphoma 20050601 |
| [Reversal of multidrug resistance of HL-60 adriamycin resistant leukemia cell line by quercetin and its mechanisms]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050601 |
| Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects. | Journal of drug targeting 20050601 |
| Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. | Cancer 20050515 |
| Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050515 |
| Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target. | Bioorganic & medicinal chemistry 20050502 |
| One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission. | British journal of haematology 20050501 |
| Precursor B-cell lymphoblastic lymphoma presenting as an isolated external ear swelling in a two-year-old child. | International journal of pediatric otorhinolaryngology 20050501 |
| Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. | The Journal of pediatrics 20050501 |
| Limited value of FLT3 mRNA expression in the bone marrow for prognosis and monitoring of patients with acute myeloid leukemia. | Haematologica 20050501 |
| Trimers of N-alkylglycines are potent modulators of the multidrug resistance phenotype. | The Journal of pharmacology and experimental therapeutics 20050401 |
| Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. | Leukemia 20050401 |
| Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050401 |
| Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial. | British journal of haematology 20050401 |
| Immunocytochemistry for drugs containing an aliphatic primary amino group in the molecule, anticancer antibiotic daunomycin as a model. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20050401 |
| Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. | Cancer cell 20050401 |
| [Influence of cytochrome C on apoptosis induced by daunorubicine in acute myeloid leukemia (AML) cells]. | Zhongguo shi yan xue ye xue za zhi 20050401 |
| Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050401 |
| Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. | Biochemistry 20050322 |
| New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors. | Drug metabolism and disposition: the biological fate of chemicals 20050301 |
| Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated. | Leukemia & lymphoma 20050301 |
| Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits. | Pharmacological research 20050301 |
| Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci. | British journal of haematology 20050301 |
| Toxicity of the topoisomerase II inhibitors. | Expert opinion on drug safety 20050301 |
| Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. | Transplant infectious disease : an official journal of the Transplantation Society 20050301 |
| The Gly-Arg-rich C-terminal domain of pea nucleolin is a DNA helicase that catalytically translocates in the 5'- to 3'-direction. | Archives of biochemistry and biophysics 20050215 |
| Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL). | Leukemia & lymphoma 20050201 |
| Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120 |
| Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives. | Carbohydrate research 20050117 |
| [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary]. | Orvosi hetilap 20050109 |
| Interaction between cardiac calsequestrin and drugs with known cardiotoxicity. | Molecular pharmacology 20050101 |
| Molecular mechanisms and kinetics between DNA and DNA binding ligands. | Biophysical journal 20050101 |
| Induction chemotherapy for acute myelogenous leukemia. | Current hematology reports 20050101 |
| The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species. | Anti-cancer drugs 20050101 |
| Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995). | Leukemia & lymphoma 20050101 |
| [Acute myelomonocytic leukemia complicated with multiple lower intestinal ulcers induced by nonsteroidal anti-inflammatory drugs]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050101 |
| Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. | Cellular oncology : the official journal of the International Society for Cellular Oncology 20050101 |
| In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model. | Anticancer research 20050101 |
| Outcome of acute myeloid leukaemia in adults: a retrospective analysis. | The National medical journal of India 20050101 |
| Flow cytometric monitoring of fluorescent drug retention and efflux. | Methods in molecular medicine 20050101 |
| Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts. | BMC cancer 20050101 |
| Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone. | Acta biochimica Polonica 20050101 |
| [Treatment of adult Berkitt-like lymphoma]. | Terapevticheskii arkhiv 20050101 |
| Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients. | Neoplasma 20050101 |
| Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy. | Neoplasma 20050101 |
| Influence of the structure of new anthracycline antibiotics on their biological properties. | Anticancer research 20050101 |
| Anthracyclines, proteasome activity and multi-drug-resistance. | BMC cancer 20050101 |
| Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP. | BMC cancer 20050101 |
| Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. | Klinische Padiatrie 20050101 |
| Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety. | Cell biology and toxicology 20050101 |
| Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia. | Pediatric dermatology 20050101 |
| Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase. | Cardiovascular toxicology 20050101 |
| 6-mercaptopurine and daunorubicin double drug liposomes-preparation, drug-drug interaction and characterization. | Journal of liposome research 20050101 |
| Control of acute myeloid leukemia morbidity in northwest Iran. | Asian Pacific journal of cancer prevention : APJCP 20050101 |
| Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells. | Blood 20041215 |
| Unusual sites of metastatic malignancy: case 3. Acute leukemia presenting as bilateral proptosis. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041215 |
| Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin. | Biochemical pharmacology 20041201 |
| An extra X chromosome as a sole abnormality in relapse of an adult acute lymphoblastic leukemia. | Cancer genetics and cytogenetics 20041201 |
| Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041201 |
| [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM]. | Ai zheng = Aizheng = Chinese journal of cancer 20041201 |
| [Inducing effect of cyclosporin A on apoptosis of multidrug resistant cell lines HR20 and HT9]. | Ai zheng = Aizheng = Chinese journal of cancer 20041201 |
| [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases]. | Ai zheng = Aizheng = Chinese journal of cancer 20041201 |
| Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia. | Leukemia & lymphoma 20041201 |
| Use of liposomal anthracyclines in Kaposi's sarcoma. | Seminars in oncology 20041201 |
| Role of liposomal anthracyclines in the treatment of multiple myeloma. | Seminars in oncology 20041201 |
| Cardiac safety of liposomal anthracyclines. | Seminars in oncology 20041201 |
| Pharmacoeconomics of liposomal anthracycline therapy. | Seminars in oncology 20041201 |
| Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. | Blood 20041115 |
| Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. | Annals of hematology 20041101 |
| Teaching cases from the Royal Marsden and St Mary's Hospitals case 28: a patient with acute leukemia with rare leukemic cells of unusual morphology. | Leukemia & lymphoma 20041101 |
| Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101 |
| Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling. | Anti-cancer drugs 20041101 |
| An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF. | Thrombosis and haemostasis 20041101 |
| [Pharmacological adjuvants for surgical treatment of proliferative vitreoretinopathy]. | Journal francais d'ophtalmologie 20041101 |
| [Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients]. | Ai zheng = Aizheng = Chinese journal of cancer 20041101 |
| [Infection control in neutropenia induced by high-dose cytarabine chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041101 |
| Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells. | British journal of pharmacology 20041001 |
| Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance. | Cancer research 20041001 |
| Testicular granulocytic sarcoma, a source of diagnostic confusion. | Urology 20041001 |
| Blanchaquinone: a new anthraquinone from an Australian Streptomyces sp. | Journal of natural products 20041001 |
| [Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol]. | Srpski arhiv za celokupno lekarstvo 20041001 |
| A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment. | Acta medica Okayama 20041001 |
| Antigenotoxic and antioxidant effect of grapefruit juice in mice treated with daunorubicin. | Toxicology letters 20040925 |
| Crystal structure of a ternary complex of DnrK, a methyltransferase in daunorubicin biosynthesis, with bound products. | The Journal of biological chemistry 20040924 |
| A mass spectrometric investigation of non-covalent interactions between ruthenium complexes and DNA. | Dalton transactions (Cambridge, England : 2003) 20040907 |
| Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06. | Biochemical pharmacology 20040901 |
| Sequence selective binding of bis-daunorubicin WP631 to DNA. | European journal of biochemistry 20040901 |
| Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. | Cancer research 20040901 |
| Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country. | British journal of haematology 20040901 |
| Thiol oxidation induced by oxidative action of adriamycin. | Free radical research 20040901 |
| ydaG and ydbA of Lactococcus lactis encode a heterodimeric ATP-binding cassette-type multidrug transporter. | The Journal of biological chemistry 20040813 |
| Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. | The New England journal of medicine 20040805 |
| Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia. | American journal of hematology 20040801 |
| Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. | The Journal of pharmacy and pharmacology 20040801 |
| Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR. | Biochemical and biophysical research communications 20040730 |
| Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells. | Biochemical and biophysical research communications 20040730 |
| Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger? | Annals of hematology 20040701 |
| Acetaminophen stimulates the peroxidative metabolism of anthracyclines. | Archives of biochemistry and biophysics 20040701 |
| DNA intercalators differentially affect chromatin structure and DNA replication in Xenopus egg extract. | Anti-cancer drugs 20040701 |
| Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. | Journal of pediatric hematology/oncology 20040701 |
| Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. | American journal of hematology 20040701 |
| Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. | Haematologica 20040701 |
| Chemotherapy-induced leukonychia. | Haematologica 20040701 |
| A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5). | Clinical cancer research : an official journal of the American Association for Cancer Research 20040615 |
| Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial. | Annals of hematology 20040601 |
| A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. | International journal of oncology 20040601 |
| Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents. | European journal of heart failure 20040601 |
| Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20040601 |
| Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia. | The New England journal of medicine 20040520 |
| Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. | Leukemia 20040501 |
| Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. | European journal of haematology 20040501 |
| Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023. | Cancer chemotherapy and pharmacology 20040501 |
| Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside. | Biochemical pharmacology 20040501 |
| Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia. | Haematologica 20040501 |
| Ceramide : A New Target in Anticancer Research? | Bulletin du cancer 20040501 |
| Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines. | The Journal of biological chemistry 20040430 |
| Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). | Biochemical pharmacology 20040415 |
| Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415 |
| Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation. | Archives of pathology & laboratory medicine 20040401 |
| N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. | Biophysical chemistry 20040401 |
| Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat. | European journal of haematology 20040401 |
| [Study on the relationship between [Ca2+]i and the MDR formation in K562/A02 cells]. | Zhongguo shi yan xue ye xue za zhi 20040401 |
| [Preliminary study of DA or HA regimen chemotherapy for the treatment of refractory and relapsed paroxysmal nocturnal hemoglobinuria]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040401 |
| Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin. | Journal of chemotherapy (Florence, Italy) 20040401 |
| The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol. | Bulletin du cancer 20040401 |
| Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: Implications in multidrug resistance in cancer. | International journal of cancer 20040320 |
| Relationship between daunorubicin concentration and apoptosis induction in leukemic cells. | Biochemical pharmacology 20040315 |
| Studies on pyrrolopyrimidines as selective inhibitors of multidrug-resistance-associated protein in multidrug resistance. | Journal of medicinal chemistry 20040311 |
| P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii. | Molecular and biochemical parasitology 20040301 |
| Granulocytic sarcoma of the testis. | Urology 20040301 |
| [Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040301 |
| [Effect of ATRA and DNR on the expression and secretion of VEGF in leukemic cells]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040301 |
| Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. | Cancer research 20040215 |
| Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A. | Journal of medicinal chemistry 20040212 |
| Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1. | The international journal of biochemistry & cell biology 20040201 |
| Simple, semiautomatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser scanning cytometry: effects of the bis-intercalator WP631 on growth and cell cycle of T-24 cells. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20040201 |
| Does anthracycline administration by infusion in children affect late cardiotoxicity? | British journal of haematology 20040201 |
| Biodistribution study of doxorubicin encapsulated in liposomes: influence of peptide coating and lipid composition. | Preparative biochemistry & biotechnology 20040201 |
| Fluorescent modified phosphatidylcholine floppase activity of reconstituted multidrug resistance-associated protein MRP1. | Biochimica et biophysica acta 20040128 |
| Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. | Biochemical pharmacology 20040115 |
| Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. | Leukemia research 20040101 |
| Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101 |
| Uncommon presentations of Hodgkin's disease. Case 2. Hodgkin's disease of the nasopharynx. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101 |
| Synthesis of a library of 3-oxopiperazinium and perhydro-3-oxo-1,4-diazepinium derivatives and identification of bioactive compounds. | Journal of combinatorial chemistry 20040101 |
| Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy. | European journal of haematology 20040101 |
| Proteomic signatures for daunomycin and adriamycin in Bacillus subtilis. | Die Pharmazie 20040101 |
| Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines. | International journal of hematology 20040101 |
| Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors. | Journal of neuro-oncology 20040101 |
| P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults. | Annals of hematology 20040101 |
| Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test. | Environmental and molecular mutagenesis 20040101 |
| Fluorescence-based assessment of LRP activity: a comparative study. | Anticancer research 20040101 |
| [Consolidation of therapy of acute myeloid leukemia with the AML-BFM 93 protocol in children in the Czech Republic]. | Casopis lekaru ceskych 20040101 |
| [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias]. | Terapevticheskii arkhiv 20040101 |
| [Damage of vascular endothelium in the treatment of acute leukemia: in vitro study]. | Terapevticheskii arkhiv 20040101 |
| Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. | Indian journal of cancer 20040101 |
| An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis. | Anticancer research 20040101 |
| Interactions of novel morpholine and hexamethylene derivatives of anthracycline antibiotics with DNA. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20040101 |
| CP-31398, a putative p53-stabilizing molecule tested in mammalian cells and in yeast for its effects on p53 transcriptional activity. | Journal of negative results in biomedicine 20040101 |
| The ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase. | Oncology research 20040101 |
| Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol. | Acta haematologica 20040101 |
| A bitter melon extract inhibits the P-glycoprotein activity in intestinal Caco-2 cells: monoglyceride as an active compound. | BioFactors (Oxford, England) 20040101 |
| [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20040101 |
| [Vitrectomy with daunorubicin]. | Klinika oczna 20040101 |
| [Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group]. | Przeglad lekarski 20040101 |
| [Diagnostic significance of reticulocyte analysis by flow cytometry, in children with acute lymphoblastic leukaemia (ALL) on chemotherapy]. | Medycyna wieku rozwojowego 20040101 |
| Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro. | Blood 20031215 |
| Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. | Blood 20031215 |
| 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215 |
| Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60. | The Journal of biological chemistry 20031212 |
| Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A. | International journal of cancer 20031210 |
| In vitro antileukemic effect of a new anthracycline analogue, MEN 11079. | Leukemia research 20031201 |
| Pumping of drugs by P-glycoprotein: a two-step process? | The Journal of pharmacology and experimental therapeutics 20031201 |
| Structure of DNA hexamer sequence d-CGATCG by two-dimensional nuclear magnetic resonance spectroscopy and restrained molecular dynamics. | Journal of biomolecular structure & dynamics 20031201 |
| Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. | British journal of haematology 20031201 |
| Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. | Bone marrow transplantation 20031201 |
| Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells. | The Journal of endocrinology 20031201 |
| Chloroma of the orbit in a non-leukemic adult: A case report. | Orbit (Amsterdam, Netherlands) 20031201 |
| MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia. | International journal of hematology 20031201 |
| [Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20031201 |
| Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina. | Medical and pediatric oncology 20031101 |
| Acute myeloid leukemia presenting as non-neutropenic colitis in an infant. | Journal of pediatric gastroenterology and nutrition 20031101 |
| Liposomal daunorubicin (DaunoXome) in multiple myeloma: a modified VAD regimen using short-term infusion. | Anti-cancer drugs 20031101 |
| Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. | Journal of pharmaceutical sciences 20031101 |
| Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. | Haematologica 20031101 |
| Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy. | Cancer chemotherapy and pharmacology 20031101 |
| Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk. | European journal of haematology 20031101 |
| Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. | The Journal of pharmacy and pharmacology 20031101 |
| FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. | Blood 20031001 |
| Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia. | Leukemia research 20031001 |
| Population pharmacokinetics of liposomal daunorubicin in children. | British journal of clinical pharmacology 20031001 |
| Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. | Biochemical pharmacology 20031001 |
| Chemotherapy increases transgene expression in leukemic cells. | The journal of gene medicine 20031001 |
| [Hematologic tumors]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031001 |
| Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. | Blood 20030915 |
| Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications. | Biochemical pharmacology 20030915 |
| Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activity. | British journal of cancer 20030915 |
| Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center. | Cancer 20030915 |
| Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity. | Cancer research 20030915 |
| BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. | Blood 20030901 |
| Identification of binding mechanisms in single molecule-DNA complexes. | Biophysical journal 20030901 |
| Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1). | Biophysical journal 20030901 |
| No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease. | Leukemia 20030901 |
| Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. | Journal of pediatric hematology/oncology 20030901 |
| A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486). | Leukemia & lymphoma 20030901 |
| Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement. | Leukemia & lymphoma 20030901 |
| Pulmonary embolism and thrombotic thrombocytopenic purpura in acute promyelocytic leukemia treated with all-trans retinoic acid. | Leukemia & lymphoma 20030901 |
| Quantitative evaluation of isothiocyanates as substrates and inhibitors of P-glycoprotein. | The Journal of pharmacy and pharmacology 20030901 |
| Chromosomal rearrangement in Down syndrome with acute myeloid leukemia. | Indian journal of pediatrics 20030901 |
| Isolated IgA deficiency after chemotherapy for acute myelogenous leukemia in an infant. | Pediatric hematology and oncology 20030901 |
| Protein profiling in daunorubicin-induced cardiomyopathy. | General physiology and biophysics 20030901 |
| Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia. | International journal of oncology 20030801 |
| A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement. | Clinical and laboratory haematology 20030801 |
| Acute arterial thrombosis in acute promyelocytic leukaemia. | Clinical and laboratory haematology 20030801 |
| New designs for phase 2 clinical trials. | Blood 20030715 |
| Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. | Blood 20030715 |
| Crystal structure of chartreusin derivative A132. | Carbohydrate research 20030704 |
| Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. | Cancer chemotherapy and pharmacology 20030701 |
| Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. | International journal of oncology 20030701 |
| Safety of high-dose liposomal daunorubicin (daunoxome) for refractory or relapsed acute myeloblastic leukaemia. | British journal of haematology 20030701 |
| Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: modulation by CD95L. | Investigative ophthalmology & visual science 20030701 |
| Oxidation of anthracycline anticancer agents by the peroxidase mimic microperoxidase 11 and hydrogen peroxide. | Free radical biology & medicine 20030701 |
| [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20030701 |
| Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis. | The Biochemical journal 20030615 |
| New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA. | Chemico-biological interactions 20030615 |
| Stress-induced activation of GATA-4 in cardiac muscle cells. | Free radical biology & medicine 20030615 |
| Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias. | Hematology (Amsterdam, Netherlands) 20030601 |
| Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. | Cancer 20030601 |
| Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. | British journal of haematology 20030601 |
| Cytosolic beta-glycosidases for activation of glycoside prodrugs of daunorubicin. | Biochemical pharmacology 20030601 |
| Anthracycline-dependent heat-induced transition from positive to negative supercoiled DNA. | Electrophoresis 20030601 |
| Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol. | Chemotherapy 20030601 |
| [Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20030601 |
| Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues. | Journal of medicinal chemistry 20030522 |
| Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. | Brain research 20030509 |
| Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia. | Blood 20030501 |
| Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. | Blood 20030501 |
| Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. | Leukemia research 20030501 |
| Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines. | Leukemia research 20030501 |
| Immunophenotyping is an independent factor for risk stratification in AML. | Cytometry. Part B, Clinical cytometry 20030501 |
| Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. | Leukemia 20030501 |
| Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML. | Blood 20030415 |
| The endonuclease NL1Tc encoded by the LINE L1Tc from Trypanosoma cruzi protects parasites from daunorubicin DNA damage. | Biochimica et biophysica acta 20030415 |
| Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415 |
| Structure of the first parallel DNA quadruplex-drug complex. | Journal of the American Chemical Society 20030409 |
| Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin. | Biochemical and biophysical research communications 20030404 |
| Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. | Blood 20030401 |
| A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia. | Leukemia research 20030401 |
| Modeling the metabolism of idarubicin to idarubicinol in rat heart: effect of rutin and phenobarbital. | Drug metabolism and disposition: the biological fate of chemicals 20030401 |
| Multiple alterations of canalicular membrane transport activities in rats with CCl(4)-induced hepatic injury. | Drug metabolism and disposition: the biological fate of chemicals 20030401 |
| Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. | Cancer 20030401 |
| Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature. | European journal of haematology 20030401 |
| A novel nuclear DNA helicase with high specific activity from Pisum sativum catalytically translocates in the 3'-->5' direction. | European journal of biochemistry 20030401 |
| Autologous peripheral blood stem cell transplantation in first remission adult acute myeloid leukaemia--an intention to treat analysis and comparison of outcome using a predictive model based on the MRC AML10 cohort. | Hematology (Amsterdam, Netherlands) 20030401 |
| Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells. | International journal of cancer 20030301 |
| Successful chemotherapy for melanotic neuroectodermal tumor of infancy in a baby. | Medical and pediatric oncology 20030301 |
| High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait. | Pediatric hematology and oncology 20030301 |
| Benign intracranial hypertension in association with acute lymphoblastic leukemia. | Pediatric hematology and oncology 20030301 |
| A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome. | Cancer 20030301 |
| Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. | The Journal of pharmacology and experimental therapeutics 20030301 |
| Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. | Leukemia 20030301 |
| Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells. | Molecular cancer therapeutics 20030301 |
| Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. | Planta medica 20030301 |
| Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly. | Leukemia & lymphoma 20030301 |
| The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. | Leukemia & lymphoma 20030301 |
| RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance. | Cellular and molecular life sciences : CMLS 20030301 |
| Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin. | Blood 20030215 |
| Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. | The Biochemical journal 20030215 |
| Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML. | Leukemia research 20030201 |
| Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. | Journal of pharmaceutical sciences 20030201 |
| RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. | Cancer gene therapy 20030201 |
| High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study. | Bone marrow transplantation 20030201 |
| Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells. | Cancer chemotherapy and pharmacology 20030201 |
| The cell cycle distribution of cultured human retinal pigmented epithelial cells under exposure of anti-proliferative drugs. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030201 |
| AML1 amplification in a child with acute lymphoblastic leukemia. | Cancer genetics and cytogenetics 20030101 |
| Morphological and biochemical changes in human fibroblast lines induced by anthracyclines during apoptosis. | Cellular & molecular biology letters 20030101 |
| [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030101 |
| High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia. | The hematology journal : the official journal of the European Haematology Association 20030101 |
| [Selective isolation of actinomycetes of the genus Actinomadura from soil]. | Mikrobiologiia 20030101 |
| Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. | Cancer science 20030101 |
| [The assessment of plasma levels of insulin-like growth factor (IGF-I) and binding protein (IGFBP-3) during the maintenance therapy and after remissionof acute lymphoblastic leukemia (ALL)]. | Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych 20030101 |
| [The influence of age, gender and modifications of therapeutic protocols on physical development of children and adolescents after completion of therapy for acute lymphoblastic leukemia]. | Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych 20030101 |
| A case of leukemia of the appendix presenting as acute appendicitis. | Acta haematologica 20030101 |
| Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia. | Clinical pharmacokinetics 20030101 |
| [Karyotype in acute myeloid leukemia: importance and type of aberrations in 30 patients at diagnosis]. | Revista da Associacao Medica Brasileira (1992) 20030101 |
| Liposomal anthracyclines in metastatic breast cancer: clinical update. | The oncologist 20030101 |
| Changes in GSH-antioxidant system induced by daunorubicin in human normal and diabetic fibroblasts. | Acta biochimica Polonica 20030101 |
| [Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic]. | Casopis lekaru ceskych 20030101 |
| Drug targeting by macromolecules without recognition unit? | Journal of molecular recognition : JMR 20030101 |
| Effect of quercetin on daunorubicin-induced heart mitochondria changes in rats. | Physiological research 20030101 |
| Granulocytic sarcoma of the pancreas. A report of one case and review of the literature. | Acta haematologica 20030101 |
| The interaction of daunorubicin and mitoxantrone with the red blood cells of acute myeloid leukemia patients. | Cellular & molecular biology letters 20030101 |
| Acute leukemia in pregnancy with ovarian metastasis: a case report and review of the literature. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101 |
| [Effect of perfluoroorganic compounds on growth of streptomycetes and biosynthesis of antibiotic daunorubicin]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101 |
| Anthracyclines. | Cancer chemotherapy and biological response modifiers 20030101 |
| Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy. | The Journal of biological chemistry 20021220 |
| Synthesis and cytotoxic activity of a new potent daunomycinone derivative. | Bioorganic & medicinal chemistry letters 20021216 |
| All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. | Blood 20021215 |
| Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). | Blood 20021215 |
| Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines. | Cancer letters 20021215 |
| Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis. | Journal of chromatography. A 20021206 |
| Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. | Apoptosis : an international journal on programmed cell death 20021201 |
| Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study. | Blood 20021201 |
| Design, synthesis and antitumor activities of novel 7-arylseleno-7-deoxydaunomycinone derivatives. | Bioorganic & medicinal chemistry 20021201 |
| P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. | Journal of pharmaceutical sciences 20021201 |
| Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation. | Molecular pharmacology 20021201 |
| Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. | Bone marrow transplantation 20021201 |
| Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia. | Bone marrow transplantation 20021201 |
| Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute myeloid leukemia. | International journal of hematology 20021201 |
| Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits. | Human & experimental toxicology 20021201 |
| Promoter-specific inhibition of transcription by daunorubicin in Saccharomyces cerevisiae. | The Biochemical journal 20021115 |
| Analysis of rat bone marrow by flow cytometry following in vivo exposure to cyclohexanone oxime or daunomycin HCl. | Toxicology and applied pharmacology 20021115 |
| Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. | Leukemia 20021101 |
| Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression. | American journal of hematology 20021101 |
| The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia. | Experimental hematology 20021101 |
| Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group. | Journal of pediatric hematology/oncology 20021101 |
| Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate. | Journal of pediatric hematology/oncology 20021101 |
| Blast crisis of chronic myeloid leukemia: diagnosis prompted by T(8;9). | Journal of pediatric hematology/oncology 20021101 |
| Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure. | Journal of pediatric hematology/oncology 20021101 |
| Liposomal daunorubicin overcomes drug resistance in human breast, ovarian and lung carcinoma cells. | Journal of liposome research 20021101 |
| [Effect of tetrandrine and droloxifene on the reversion of drug resistance of K562/A02 cell line and induction of apoptosis]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20021101 |
| Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group. | Blood 20021015 |
| Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015 |
| Inhibition of basal and transforming growth factor-beta-induced stimulation of COL1A1 transcription by the DNA intercalators, mitoxantrone and WP631, in cultured human dermal fibroblasts. | The Journal of biological chemistry 20021011 |
| Daunorubicin- and Ara-C-induced interphasic apoptosis of human type II leukemia cells is caspase-8-independent. | Biochimica et biophysica acta 20021010 |
| Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. | The Biochemical journal 20021001 |
| Ara-C- and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane rafts. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20021001 |
| Role of daunorubicin in inhibiting proliferative vitreoretinopathy after retinal detachment surgery. | Clinical & experimental ophthalmology 20021001 |
| Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine. | Pharmaceutical research 20021001 |
| Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22). | European journal of haematology 20021001 |
| Long-term outcomes of acute myeloid leukemia in adults in Pakistan. | JPMA. The Journal of the Pakistan Medical Association 20021001 |
| Induction of metallothionein by zinc protects from daunorubicin toxicity in rats. | Toxicology 20020930 |
| Inhibitory effect of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methyl methanesulfonate in mouse bone marrow. | Toxicology letters 20020905 |
| Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. | Journal of pineal research 20020901 |
| Management of acute promyelocytic leukemia. | Current oncology reports 20020901 |
| Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia. | Leukemia 20020901 |
| A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. | American journal of hematology 20020901 |
| Central nervous system relapse in acute promyelocytic leukemia. | American journal of hematology 20020901 |
| Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient. | Internal medicine (Tokyo, Japan) 20020901 |
| [In vitro study of the apoptosis effect of DNR on HL-60 cells and its relationship with ROS, CER and NF-kappaB]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020901 |
| Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720. | Blood 20020815 |
| Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R. | World journal of gastroenterology 20020815 |
| Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecin. | Journal of pharmaceutical sciences 20020801 |
| Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells. | Molecular pharmacology 20020801 |
| SAB--a promising new treatment to improve remission rates in AML in the elderly? | British journal of haematology 20020801 |
| Anti-angiogenic activity of the purine analog 6-thioguanine. | Leukemia 20020801 |
| In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy. | Bone 20020801 |
| Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome. | Haematologica 20020801 |
| Tuberculosis and immune thrombocytopenia. | Haematologica 20020801 |
| Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020801 |
| Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia. | Annals of hematology 20020801 |
| [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20020710 |
| CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. | Leukemia research 20020701 |
| Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. | Cancer gene therapy 20020701 |
| A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer. | British journal of cancer 20020701 |
| Suicide gene therapy using E. coli beta-galactosidase. | Cancer chemotherapy and pharmacology 20020701 |
| Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia. | Medical and pediatric oncology 20020701 |
| Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)? | Medical and pediatric oncology 20020701 |
| Increased factor VIII activity and dural sinus thrombosis. | Medical and pediatric oncology 20020701 |
| Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells. | Journal of cancer research and clinical oncology 20020701 |
| Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro. | Anti-cancer drugs 20020701 |
| Spectroelectrochemical study of the interaction between antitumor drug daunomycin and DNA in the presence of antioxidants. | Journal of pharmaceutical and biomedical analysis 20020620 |
| Potent inhibition of DNA unwinding and ATPase activities of pea DNA helicase 45 by DNA-binding agents. | Biochemical and biophysical research communications 20020607 |
| Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571. | Leukemia 20020601 |
| Competitive interaction of the antitumor drug daunorubicin and the fluorescence probe ethidium bromide with DNA as studied by resolving trilinear fluorescence data: the use of PARAFAC and its modification. | Analytical and bioanalytical chemistry 20020601 |
| Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. | Rheumatology (Oxford, England) 20020601 |
| Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells. | Cancer chemotherapy and pharmacology 20020601 |
| Downregulation of taurine uptake in multidrug resistant Ehrlich ascites tumor cells. | Amino acids 20020601 |
| Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis. | Proteomics 20020601 |
| Tetrasomy 13 as the sole cytogenetic abnormality in acute myeloid leukemia M1 without maturation. | Cancer genetics and cytogenetics 20020601 |
| A case of acantholytic dermatosis and leukemia cutis: cause or effect? | The American Journal of dermatopathology 20020601 |
| Transfusion medicine illustrated. White out: extreme leukocytosis treated with WBC reduction. | Transfusion 20020601 |
| Methotrexate induced seizures associated with acute reversible magnetic resonance imaging (MRI) changes in a patient with acute lymphoblastic leukemia. | Leukemia & lymphoma 20020601 |
| Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapy. | European journal of haematology 20020601 |
| Drug sensitivity assay for leukaemic cells by flow cytometry. | The Indian journal of medical research 20020601 |
| Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. | Biochemical and biophysical research communications 20020524 |
| Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515 |
| Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cells. | Biochemical pharmacology 20020515 |
| Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study. | Cancer 20020515 |
| Gynecomastia with marked cellular atypia associated with chemotherapy. | Archives of pathology & laboratory medicine 20020501 |
| Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition. | Molecular pharmacology 20020501 |
| Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells. | British journal of haematology 20020501 |
| Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. | Cancer chemotherapy and pharmacology 20020501 |
| Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. | Journal of pharmaceutical sciences 20020501 |
| Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin. | Leukemia 20020501 |
| NMR determination of the hetero-association of phenanthridines with daunomycin and their competitive binding to a DNA oligomer. | European biophysics journal : EBJ 20020501 |
| Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells. | Breast cancer research and treatment 20020501 |
| Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance. | Cancer letters 20020425 |
| Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine. | Biochemical pharmacology 20020415 |
| Interaction of daunomycin antibiotic with histone H(1): ultraviolet spectroscopy and equilibrium dialysis studies. | International journal of biological macromolecules 20020408 |
| Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide. | American journal of hematology 20020401 |
| Effects of dietary lipids on daunomycin-induced nephropathy in mice: comparison between cod liver oil and soybean oil. | Lipids 20020401 |
| D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. | Experimental & molecular medicine 20020331 |
| Differential destabilization of membranes by tryptophan and phenylalanine during freezing: the roles of lipid composition and membrane fusion. | Biochimica et biophysica acta 20020319 |
| Enantioselective synthesis of (+)-4-demethoxy-1,4-dimethyldaunomycinone. | Bioorganic & medicinal chemistry 20020301 |
| Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity. | Molecular pharmacology 20020301 |
| Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. | The Journal of pharmacology and experimental therapeutics 20020301 |
| Chemotherapy and pregnancy. | Clinical obstetrics and gynecology 20020301 |
| Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy. | Haematologica 20020301 |
| Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance. | Bioorganic & medicinal chemistry letters 20020225 |
| Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia. | Leukemia research 20020201 |
| Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report. | Leukemia research 20020201 |
| Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. | American journal of clinical oncology 20020201 |
| Electrochemical evaluation of the interaction between endocrine disrupter chemicals and estrogen receptor using 17,beta-estradiol labeled with daunomycin. | Analytical chemistry 20020201 |
| Hematopoietic cell transplantation beyond first remission. | Leukemia 20020201 |
| Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. | Leukemia 20020201 |
| Diversity of the apoptotic response to chemotherapy in childhood leukemia. | Leukemia 20020201 |
| C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells. | Leukemia 20020201 |
| Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study. | British journal of haematology 20020201 |
| Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20020201 |
| Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines. | International journal of hematology 20020201 |
| In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1. | Cancer research 20020115 |
| The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. | Oncogene 20020103 |
| PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. | Leukemia research 20020101 |
| Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases. | International journal of hematology 20020101 |
| Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy. | International journal of hematology 20020101 |
| In vitro studies of haematopoietic colony-forming capacity of human fetal liver cells at exposure to cytotoxic and immunomodulatory drugs. | Fetal diagnosis and therapy 20020101 |
| Assessment of drug activity and proliferation ex vivo for prediction of outcome in aggressive non-Hodgkin's lymphomas. | Acta oncologica (Stockholm, Sweden) 20020101 |
| Imaging of P glycoprotein function in vivo with PET. | Novartis Foundation symposium 20020101 |
| Correlation of histopathological and biochemical appraisal of anthracyclin-induced myocardium damage. | Folia histochemica et cytobiologica 20020101 |
| Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. | Blood cells, molecules & diseases 20020101 |
| Involvement of glutathione and glutathione-related enzymes in the protection of normal and trisomic human fibroblasts against daunorubicin. | Cell biology international 20020101 |
| Overexpression of protein disulfide isomerase-like protein in a mouse leukemia L1210 cell line selected for resistance to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a ribonucleotide reductase inhibitor. | Advances in enzyme regulation 20020101 |
| The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia. | Acta biochimica Polonica 20020101 |
| Troponins in experimental studies. | Acta medica (Hradec Kralove) 20020101 |
| CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. | Acta haematologica 20020101 |
| [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children]. | Klinische Padiatrie 20020101 |
| [Effect of intercalators on the properties of liquid-crystalline dispersions of nucleic acid-chitosan complex]. | Molekuliarnaia biologiia 20020101 |
| Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. | Anticancer research 20020101 |
| [Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia]. | Terapevticheskii arkhiv 20020101 |
| Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity. | Cardiovascular toxicology 20020101 |
| Effect of aging on cardiac contractility in a rat model of chronic daunorubicin cardiotoxicity. | Cardiovascular toxicology 20020101 |
| PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro. | Neoplasma 20020101 |
| [NMR study of complex formation of aromatic ligands with heptadeoxynucleotide 5'-d(GCGAAGC) forming stable hairpin structure in aqueous solution]. | Molekuliarnaia biologiia 20020101 |
| P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs. | Journal of experimental therapeutics & oncology 20020101 |
| [Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000]. | Voprosy onkologii 20020101 |
| Bilateral retinal hemorrhages in an 18-year-old woman. | Survey of ophthalmology 20020101 |
| Effect of sodium 2,3-dimercaptopropane-1-sulphonate (DMPS) on chronic daunorubicin toxicity in rabbits: comparison with dexrazoxane. | Acta medica (Hradec Kralove) 20020101 |
| Effect of melatonin on cytotoxic effects of daunorubicin on myocardium and on transplantable Morris hepatoma in rats. | Polish journal of pathology : official journal of the Polish Society of Pathologists 20020101 |
| Apoptosis of leukemia cells induced by CD34+ cells transferred exogenous Fas ligand. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20020101 |
| Maximum-entropy determination of self-association distribution functions; daunorubicin and ATP. | Biophysical chemistry 20011225 |
| Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin. | Biochemistry 20011218 |
| Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. | The EMBO journal 20011203 |
| A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines. | International journal of oncology 20011201 |
| Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. | Blood 20011201 |
| Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. | Journal of pediatric hematology/oncology 20011201 |
| Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. | Journal of pediatric hematology/oncology 20011201 |
| Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation. | Journal of pediatric hematology/oncology 20011201 |
| An adjustment for a post-randomization variable in the comparison of two treatments for survival. | Statistics in medicine 20011130 |
| Anthracyclines: recent developments in their separation and quantitation. | Journal of chromatography. B, Biomedical sciences and applications 20011125 |
| Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability. | Biochemical and biophysical research communications 20011123 |
| Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation. | International journal of radiation oncology, biology, physics 20011115 |
| Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. | Life sciences 20011102 |
| Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia. | British journal of haematology 20011101 |
| Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines. | Anti-cancer drugs 20011101 |
| Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. | Medical and pediatric oncology 20011101 |
| Influence of P-glycoprotein modulators on cardiac uptake, metabolism, and effects of idarubicin. | Pharmaceutical research 20011101 |
| Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA. | Biochemistry 20011023 |
| The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein. | Cancer research 20011015 |
| Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets. | International journal of cancer 20011015 |
| Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma. | Oncogene 20011011 |
| Spectroscopic studies on iron complexes of different anthracyclines in aprotic solvent systems. | Inorganic chemistry 20011008 |
| The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. | Oncogene 20011004 |
| Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia. | Medical and pediatric oncology 20011001 |
| In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials? | Leukemia 20011001 |
| A pharmacokinetic study of idarubicin in Japanese patients with malignant lymphoma: relationship with leukocytopenia and neutropenia. | International journal of hematology 20011001 |
| Acute arterial occlusion as the presenting feature in acute promyelocytic leukaemia. | British journal of haematology 20011001 |
| FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia. | European journal of haematology 20011001 |
| Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia. | European journal of haematology 20011001 |
| Development of obesity and neurochemical backing in aurothioglucose-treated mice. | Autonomic neuroscience : basic & clinical 20010917 |
| Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. | Blood 20010901 |
| The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. | Blood 20010901 |
| Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010901 |
| Therapy-related CD7+ acute myeloid leukemia with trisomy 8 following acute monocytic leukemia. | Anti-cancer drugs 20010901 |
| Signaling pathways activated by daunorubicin. | Blood 20010815 |
| A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. | Blood 20010815 |
| Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein. | Drug metabolism and disposition: the biological fate of chemicals 20010801 |
| Erythroleukaemia in the north of England: a population based study. | Journal of clinical pathology 20010801 |
| Production of aromatic minimal polyketides by the daunorubicin polyketide synthase genes reveals the incompatibility of the heterologous DpsY and JadI cyclases. | Journal of natural products 20010801 |
| Successful treatment of hepatosplenic candidiasis in an elderly patient with acute myeloid leukemia using liposomal daunorubicin and fluconazole. | Haematologica 20010801 |
| Determination of anthracycline antibiotics doxorubicin and daunorubicin by capillary electrophoresis with UV absorption detection. | Electrophoresis 20010801 |
| Remission induction therapy: the more intensive the better? | Cancer chemotherapy and pharmacology 20010801 |
| Daunorubicin inhibits gene expression of cyclooxygenase-2 in vascular smooth muscle cells. | Thrombosis research 20010801 |
| Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis. | Journal of chromatography. B, Biomedical sciences and applications 20010715 |
| Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells. | The Journal of biological chemistry 20010706 |
| Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. | American journal of hematology 20010701 |
| Involvement of FAN in TNF-induced apoptosis. | The Journal of clinical investigation 20010701 |
| High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia. | Cancer 20010701 |
| Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. | Medical and pediatric oncology 20010701 |
| Treatment of acute promyelocytic leukaemia using a combination of all-trans retinoic acid and chemotherapy. | Annals of the Academy of Medicine, Singapore 20010701 |
| Migration of retinal pigment epithelial cells in vitro modulated by monocyte chemotactic protein-1: enhancement and inhibition. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20010701 |
| Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation. | International journal of hematology 20010701 |
| Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators. | Cancer letters 20010626 |
| Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter. | European journal of pharmacology 20010622 |
| Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome. | Journal of chromatography. B, Biomedical sciences and applications 20010615 |
| Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells. | Biochemical pharmacology 20010601 |
| Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. | Biochemical pharmacology 20010601 |
| Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial. | British journal of haematology 20010601 |
| Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia. | British journal of haematology 20010601 |
| Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells. | European journal of pharmacology 20010601 |
| Melanocyte-Directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanoma. | Bioorganic & medicinal chemistry 20010601 |
| Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. | Leukemia 20010601 |
| Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. | Leukemia 20010601 |
| The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. | Leukemia 20010601 |
| Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia. | Cancer genetics and cytogenetics 20010601 |
| True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms. | British journal of haematology 20010601 |
| [Primary pulmonary manifestation of extramedullary acute myelocytic leukemia]. | Pneumologie (Stuttgart, Germany) 20010601 |
| Recent developments in the field of antitumour anthracyclines. | European journal of medicinal chemistry 20010601 |
| Alterative and plastic insufficiency of cardiomyocytes: isoproterenol-induced damage to myocardium during anthracycline cardiomyopathy. | Bulletin of experimental biology and medicine 20010601 |
| Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma. | Leukemia & lymphoma 20010601 |
| Increase of ceramides and its inhibition by catalase during chemically induced apoptosis of HL-60 cells determined by electrospray ionization tandem mass spectrometry. | Biochimica et biophysica acta 20010531 |
| Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515 |
| Melanin potentiates daunorubicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. | European journal of pharmacology 20010511 |
| Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia. | Leukemia research 20010501 |
| Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study. | Haematologica 20010501 |
| [Subcellular distribution of daunorubicin in the P-glycoprotein-mediated multidrug-resistant cell line K562/ADR]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20010501 |
| Determination of binding thermodynamics. | Current protocols in nucleic acid chemistry 20010501 |
| Daunorubicin attenuates tumor necrosis factor-alpha-induced biosynthesis of plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. | Biochimica et biophysica acta 20010423 |
| Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010401 |
| Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562. | British journal of cancer 20010401 |
| Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). | Experimental hematology 20010401 |
| Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. | British journal of haematology 20010401 |
| Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group. | International journal of hematology 20010401 |
| PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential. | Cancer chemotherapy and pharmacology 20010401 |
| Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. | Leukemia 20010401 |
| Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase. | Leukemia & lymphoma 20010401 |
| Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20010401 |
| Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma. | Annals of oncology : official journal of the European Society for Medical Oncology 20010401 |
| Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells. | FEBS letters 20010323 |
| Total body irradiation before allogeneic bone marrow transplantation: is more dose better? | International journal of radiation oncology, biology, physics 20010315 |
| Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010315 |
| Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle. | Cytometry 20010301 |
| Liposomal encapsulated anthracyclines: new therapeutic horizons. | Current oncology reports 20010301 |
| Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. | Leukemia 20010301 |
| Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent. | Cancer research 20010301 |
| Neutrophilic eccrine hidradenitis in two neutropaenic patients. | Clinical and experimental dermatology 20010301 |
| Hydrogen peroxide and hydroxyl radical involvement in the activation of caspase-3 in chemically induced apoptosis of HL-60 cells. | Cellular and molecular life sciences : CMLS 20010301 |
| Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia. | European journal of haematology 20010301 |
| Acute myeloid leukaemia (AML): treatment of the older patient. | Best practice & research. Clinical haematology 20010301 |
| Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. | Biochemistry 20010227 |
| Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia. | British journal of haematology 20010201 |
| Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives. | Pharmacology & toxicology 20010201 |
| Hepatic dysfunction as the presenting feature of acute lymphoblastic leukemia. | Journal of pediatric hematology/oncology 20010201 |
| Bilateral breast relapse in acute myelogenous leukemia. | Journal of pediatric hematology/oncology 20010201 |
| Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. | Journal of pediatric hematology/oncology 20010201 |
| Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20010201 |
| Overexpression of aldose reductase in liver cancers may contribute to drug resistance. | Anti-cancer drugs 20010201 |
| Ultrastructural changes in cardiomyocyte mitochondria during regenerative and plastic insufficiency of the myocardium. | Bulletin of experimental biology and medicine 20010201 |
| Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy. | Medical and pediatric oncology 20010201 |
| In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. | Cancer research 20010115 |
| The mechanism for anthracycline-induced inhibition of collagen biosynthesis. | European journal of pharmacology 20010105 |
| Monitoring of cellular resistance to cancer chemotherapy: drug retention and efflux. | Methods in cell biology 20010101 |
| Analysis of drug uptake-flow cytometry. | Methods in molecular biology (Clifton, N.J.) 20010101 |
| Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis. | Leukemia research 20010101 |
| De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy. | Leukemia research 20010101 |
| Antimutagenic activity of fluphenazine in short-term tests. | Mutagenesis 20010101 |
| The product of dpsC confers starter unit fidelity upon the daunorubicin polyketide synthase of Streptomyces sp. strain C5. | Metabolic engineering 20010101 |
| Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. | British journal of haematology 20010101 |
| Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells. | Cancer research 20010101 |
| Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser-induced fluorescence detection. | Electrophoresis 20010101 |
| Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia. | Cancer chemotherapy and pharmacology 20010101 |
| Cytotoxicity of daunorubicin in trisomic (+21) human fibroblasts: relation to drug uptake and cell membrane fluidity. | Cell biology international 20010101 |
| Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance. | Leukemia 20010101 |
| Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome. | Journal of clinical pathology 20010101 |
| Investigations of thyroid function in children and adolescents after treatment of Hodgkin's disease. | Medycyna wieku rozwojowego 20010101 |
| Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia. | Pediatric hematology and oncology 20010101 |
| Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia. | Pediatric hematology and oncology 20010101 |
| [Experimental chemotherapy of malignant tumors in combination with short-term general hypoxia]. | Voprosy onkologii 20010101 |
| Modulation of cancer cell multidrug resistance by an extract of Ficus citrifolia. | Anticancer research 20010101 |
| Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation. | Anticancer research 20010101 |
| A systematic overview of chemotherapy effects in acute myeloid leukaemia. | Acta oncologica (Stockholm, Sweden) 20010101 |
| New TFO conjugates containing a carminomycinone-derived chromophore. | Bioconjugate chemistry 20010101 |
| Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin. | Medical and pediatric oncology 20010101 |
| Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy. | Journal of pediatric hematology/oncology 20010101 |
| 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs. | Blood cells, molecules & diseases 20010101 |
| Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial. | Cancer investigation 20010101 |
| Simultaneous measurement of binding constants and unwinding angles by gel electrophoresis. | Methods in enzymology 20010101 |
| [Improved treatment results in children with AML: Results of study AML-BFM 93]. | Klinische Padiatrie 20010101 |
| Role of palmitoyl-protein thioesterase in cell death: implications for infantile neuronal ceroid lipofuscinosis. | European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20010101 |
| [Characteristics of mutants of Streptomyces peucetius subsp. caesius ATCC 27952 resistant to anthracycline antibiotics]. | Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 20010101 |
| Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. | Leukemia & lymphoma 20010101 |
| Cocaine-contaminated allogeneic bone marrow transplantation. | Acta haematologica 20010101 |
| Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy. | Annals of hematology 20010101 |
| Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia. | Bratislavske lekarske listy 20010101 |
| Pharmacokinetics and toxicity of idarubicin in the rat. | European journal of drug metabolism and pharmacokinetics 20010101 |
| Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics. | Neoplasma 20010101 |
| Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety. | Anticancer research 20010101 |
| Voltammetric detection of lectin using sugar labeled with electroactive substance. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20010101 |
| The effect of the Fas/FasL pathway during chemotherapeutic drug-induced apoptosis of leukaemeic cells. | Journal of Tongji Medical University = Tong ji yi ke da xue xue bao 20010101 |
| Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro. | International ophthalmology 20010101 |
| Release of plasminogen activator inhibitor-1 from human astrocytes is regulated by intracellular ceramide. | Journal of neuroscience research 20001215 |
| Focal degradation of cytoplasmic organelles in cardiomyocytes during regenerative and plastic myocardial insufficiency. | Bulletin of experimental biology and medicine 20001201 |
| Ultrastructure of nuclear compartment in cardiomyocytes during regenerative and plastic insufficiency of the myocardium. | Bulletin of experimental biology and medicine 20001201 |
| Regulation of phospholipase D activity and ceramide production in daunorubicin-induced apoptosis in A-431 cells. | Biochimica et biophysica acta 20001115 |
| [Severe hemolysis and SIADH-like symptoms induced by vincristine in an ALL patient with liver cirrhosis]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20001101 |
| Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin. | Pharmacotherapy 20001001 |
| Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat. | British journal of pharmacology 20000901 |
| Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide. | Biochemical pharmacology 20000801 |
| E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. | Cancer research 20000715 |
| Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. | Medical and pediatric oncology 20000701 |
| High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission. | Leukemia 20000701 |
| Chest and back pain associated with a six-hour infusion of liposomal daunorubicin. | The Annals of pharmacotherapy 20000601 |
| Anthracycline induced cardiomyopathy: successful treatment with angiotensin converting enzyme inhibitors. | European journal of pediatrics 20000501 |
| Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. | Cancer research 20000401 |
| Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Blood 20000101 |
| Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. | Acta haematologica 20000101 |
| Stress-induced gastric lesion formation is prevented in rats with daunomycin-induced nephrosis. | Japanese journal of pharmacology 19991001 |
| [Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 19990901 |
| Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. | Leukemia 19990701 |
| Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells. | Biochemical pharmacology 19990615 |
| Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. | Blood 19990501 |
| Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines. | Blood 19990401 |
| IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits. | Human & experimental toxicology 19990301 |
| Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors. | Pediatric hematology and oncology 19990101 |
| High density lipoprotein catabolism in primary cultured hepatocytes from daunomycin-induced nephrotic rats. | American journal of nephrology 19990101 |
| Alterations in the distribution of plasma fibronectin and the ultrastructure of podocytes in the peripheral glomerular loops in nephrotic rats. | Virchows Archiv : an international journal of pathology 19981101 |
| Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy. | Seminars in oncology 19980801 |
| Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. | Biochemical and biophysical research communications 19980629 |
| A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma. | European journal of cancer (Oxford, England : 1990) 19980601 |
| The Streptomyces peucetius dpsY and dnrX genes govern early and late steps of daunorubicin and doxorubicin biosynthesis. | Journal of bacteriology 19980501 |
| Lipid peroxidation of rat myocardial tissue following daunomycin administration. | Toxicology 19980313 |
| Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells. | International journal of cancer 19970926 |
| In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA. | Journal of bacteriology 19970401 |
| Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. | International journal of cancer 19970328 |
| A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile. | Clinical cancer research : an official journal of the American Association for Cancer Research 19970301 |
| Roles of reactive oxygen species and antioxidant enzymes in murine daunomycin-induced nephropathy. | The Journal of laboratory and clinical medicine 19970101 |
| Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. | Cancer chemotherapy and pharmacology 19970101 |
| Pericarditis induced by high-dose cytosine arabinoside chemotherapy. | Annals of hematology 19970101 |
| Double knockout of the MRP gene leads to increased drug sensitivity in vitro. | Cancer research 19961201 |
| Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency. | American journal of hematology 19961101 |
| MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver. | Cancer research 19961101 |
| Changes in cholinesterase activities after daunorubicin administration to rabbits. | Human & experimental toxicology 19961001 |
| Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation. | Molecular pharmacology 19960901 |
| Lipid peroxidation and antioxidant defense mechanisms in rat renal tissue after daunorubicin administration. | Renal failure 19960701 |
| Cloning, sequencing, and analysis of aklaviketone reductase from Streptomyces sp. strain C5. | Journal of bacteriology 19960601 |
| Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention. | British journal of pharmacology 19960401 |
| A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. | Blood 19960301 |
| Attenuation of cardiotoxicity of daunomycin using a complex with heparin. | International journal of hematology 19960101 |
| [Long-term selective beta 1-blockade therapy for a patient with anthracycline-induced cardiomyopathy]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 19951101 |
| [Chylomicron and VLDL metabolism in daunomycin-induced nephrotic rats]. | Nihon Jinzo Gakkai shi 19950701 |
| Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function. | Bone marrow transplantation 19950601 |
| Nephrotic syndrome developed in a patient with acute promyelocytic leukemia treated with daunomycin. | Nephron 19950101 |
| [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma]. | Revista espanola de cardiologia 19941101 |
| [Use of cyclosporin and verapamil in association with chemotherapy in the treatment of pediatric patients with advanced-stage neoplasms. A pilot study]. | Minerva pediatrica 19941001 |
| Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. | Leukemia 19940401 |
| Alterations in Ca2+ transport ATPase and P-glycoprotein expression can mediate resistance to thapsigargin. | The Journal of biological chemistry 19940318 |
| Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. | Molecular aspects of medicine 19940101 |
| [Rubomycin-induced cardiomyopathy in rats and the potential for therapy with a peptide preparation from the heart]. | Biulleten' eksperimental'noi biologii i meditsiny 19930901 |
| Partial purification and properties of carminomycin 4-O-methyltransferase from Streptomyces sp. strain C5. | Journal of general microbiology 19930601 |
| Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. | Leukemia & lymphoma 19930301 |
| [Lipid metabolism in daunomycin-induced nephrotic rats (Part 6)]. | Nihon Jinzo Gakkai shi 19930301 |
| Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. | Clinical oncology (Royal College of Radiologists (Great Britain)) 19930101 |
| Interstrain differences in murine daunomycin-induced nephrosis. | Nephron 19930101 |
| [Evaluation of daunorubicin nephrotoxicity and effect of tocopherol and ascorbic acid on lesions induced in rat kidneys. I. Histologic, histochemical and biochemical studies]. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 19930101 |
| The anthracyclines: will we ever find a better doxorubicin? | Seminars in oncology 19921201 |
| Bradycardia due to anthracyclines. | Lancet (London, England) 19921003 |
| Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia. | European journal of haematology 19921001 |
| Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. | Blood 19920915 |
| HIV-1 and HIV-2 reverse transcriptases: a comparative study of sensitivity to inhibition by selected natural products. | Biochemical and biophysical research communications 19920529 |
| [A successful allogeneic bone marrow transplantation for acute promyelocytic leukemia with anthracycline-induced cardiomyopathy at relapse]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 19920401 |
| Inadvertent intrathecal injection of daunorubicin with fatal outcome. | Medical and pediatric oncology 19920101 |
| [Sudden death in leukemic patients treated with doxorubicin]. | The Canadian journal of cardiology 19920101 |
| Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II. | Cancer research 19911001 |
| [Torsade de pointes ventricular tachycardia in a patient with acute myelocytic leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 19910901 |
| Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis. | The Journal of pharmacology and experimental therapeutics 19910701 |
| Thromboelastographic analysis of coagulation and fibrinolysis in rats with nephrotic syndrome induced by daunomycin. | Nihon Jinzo Gakkai shi 19910501 |
| Effect of an oral adsorbent (AST-120) in rats with daunomycin-induced chronic renal failure. | Nihon Jinzo Gakkai shi 19910501 |
| Daunorubicin, amsacrine, and sinus arrest. | The Western journal of medicine 19910401 |
| Erythroleukaemia and daunorubicin-induced cardiotoxicity in a young boy. | The British journal of clinical practice 19901201 |
| [Lipid metabolism in daunomycin-induced nephrotic rats (5)]. | Nihon Jinzo Gakkai shi 19900901 |
| Osseous changes and abnormalities of mineral metabolism in daunomycin rats. | Nihon Jinzo Gakkai shi 19900801 |
| [Daunomycin rats. Second Report. Is it possible to use daunomycin rats as an experimental model of chronic renal failure?]. | Nihon Jinzo Gakkai shi 19900201 |
| Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside. | American journal of hematology 19891201 |
| Daunorubicin-induced mammary tumors in the rat. | European journal of cancer & clinical oncology 19891101 |
| [Diagnosis and treatment of rubomycin-induced heart lesions in children with leukemia]. | Gematologiia i transfuziologiia 19890901 |
| [A model of daunorubicin-induced nephrotic syndrome in the rat]. | Zhonghua yi xue za zhi 19890501 |
| [Acute pericarditis caused by daunorubicin in acute myelocytic leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 19880601 |
| 4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study. | Tumori 19880227 |
| Phase II trial of idarubicin in patients with advanced lymphoma. | Cancer chemotherapy and pharmacology 19880101 |
| [Evaluation of peak filling rate for the early identification of daunorubicin cardiotoxicity]. | Giornale italiano di cardiologia 19880101 |
| Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. | The American journal of pathology 19871001 |
| Inhibition of herpes simplex virus replication by anthracycline compounds. | Antiviral research 19870901 |
| [Daunomycin-induced cardiogenic shock in a case of acute myelogenous leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 19870901 |
| [Morphological manifestations of anthracycline cardiomyopathy in the ventricular myocardium of the rat]. | Biulleten' eksperimental'noi biologii i meditsiny 19870701 |
| High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia. | Blood 19870301 |
| [Lipid metabolism in daunomycin induced nephrotic rats (Part III)]. | Nihon Jinzo Gakkai shi 19870201 |
| [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)]. | La Pediatria medica e chirurgica : Medical and surgical pediatrics 19870101 |
| High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia. | Oncology 19870101 |
| Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19860101 |
| A prospective study of detorubicin in malignant mesothelioma. | Cancer 19851101 |
| Detorubicin--an active anthracycline in untreated metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19851101 |
| [Experimental nephrotic hyperlipidemia induced in rats by daunorubicin and effects of KCD-232[4-(4'-chlorobenzyloxy)benzyl nicotinate] on lipid metabolism]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19850501 |
| Toxic effects of daunorubicin on isolated and cultured heart cells from neonatal rats. | Biochemical pharmacology 19850401 |
| [Left ventricular thrombosis in a case of daunomycin cardiomyopathy]. | Cardiologia (Rome, Italy) 19850201 |
| Daunomycin-induced nephropathy in rats. | Acta pathologica japonica 19850101 |
| Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19840401 |
| Mechanism of acute anthracycline cardiotoxicity in isolated rat hearts: carminomycin versus daunomycin. | Cancer research 19840401 |
| [Monitoring of heart function in the treatment with cardiotoxic cytostatic drugs]. | Onkologie 19840201 |
| [Morphological and ultrastructural indicators of early cardiotoxicity in rats after the administration of rubidomycin and its derivatives]. | Patologia polska 19840101 |
| [Effects of adriamycin and daunomycin on cardiac functions]. | Gan to kagaku ryoho. Cancer & chemotherapy 19831101 |
| Lipid metabolism in the aorta of daunomycin-induced nephrotic rats. | The Tohoku journal of experimental medicine 19831001 |
| Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse. | Cancer chemotherapy and pharmacology 19830101 |
| [Cardiotoxic effect of anthracycline antibiotics]. | Bilten za hematologiju i transfuziju 19830101 |
| Comparative cardiac and renal toxicity of daunorubicin in the rat and rabbit. | Cancer treatment reports 19820201 |
| Mitigating effects of ICRF-159 (razoxane) on a daunomycin-induced cardiomyopathy in mice. | Drug and chemical toxicology 19820101 |
| [Cardiotoxic aspects of daunorubicin used in the treatment of acute myeloblastic and lymphoblastic leukoses]. | Medicinski pregled 19810101 |
| Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia. | Cancer chemotherapy and pharmacology 19810101 |
| Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study. | The American journal of pediatric hematology/oncology 19810101 |
| Risk factors for development of daunorubicin cardiotoxicity. | Cancer treatment reports 19810101 |
| Biochemical properties of glomerular basement membrane in daunomycin nephrosis and nephrotoxic serum nephritis. | Renal physiology 19810101 |
| Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. | Cancer research 19801001 |
| Cytotoxic-induced fulminant hyperpyrexia. | Cancer 19800501 |
| Selective mitochondrial alterations induced by a single dose of daunorubicin or 4-demethoxydaunorubicin in mouse ventricular myocardium. | Tumori 19800201 |
| Daunorubicin-induced myocardial failure: reversal by digoxin of an inability to use ATP for contraction. | Journal of molecular and cellular cardiology 19800101 |
| Anthracycline cardiomyopathy in children: report of two cases. | Cancer 19791101 |
| Time- and dose-dependent changes in ejection fraction after anthracycline therapy. | Journal of cardiovascular pharmacology 19790101 |
| Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters. | Cancer treatment reports 19790101 |
| 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline. | Journal of medicinal chemistry 19790101 |
| Synthesis of daunorubicin analogues with novel 9-acyl substituents. | Journal of medicinal chemistry 19790101 |
| Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dog. | Cancer treatment reports 19790101 |
| [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 19780801 |
| Mammary tumors induced in rats by adriamycin and daunomycin. | Cancer research 19780501 |
| [Cardiotoxicity in long term treatment with cytostatics (author's transl)]. | Deutsche medizinische Wochenschrift (1946) 19780303 |
| A phase 1 and 2 trial of rubidazone in patients with acute leukemia. | Cancer research 19771201 |
| Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. | Cancer research 19770801 |
| [Pathogenesis of the toxic and allergic nephrotic syndrome. Metabolic studies on kidney-cortex slices and on glomeruli]. | Fortschritte der Medizin 19770526 |
| Doxorubicin hydrochloride-associated renal failure. | Archives of internal medicine 19770301 |
| Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. | The American journal of medicine 19770201 |
| Letter: Pericarditis in a case of early daunorubicin cardiomyopathy. | Annals of internal medicine 19760901 |
| Endomyocardial fibrosis associated with daunorubicin therapy. | British heart journal 19760801 |
| Delayed and progressive myocardial lesions after adriamycin administration in the rabbit. | Cancer research 19760801 |
| Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin. | Cancer research 19760601 |
| Daunorubicin-induced cardiotoxicity. | The West Indian medical journal 19760301 |
| The cardiotoxicity of adriamycin and daunomycin in children. | Cancer 19760201 |
| [Electrocardiographic changes in patients with acute leukoses treated with rubidomycin or adriamycin at the Internal Clinic A]. | Bilten za hematologiju i transfuziju 19760101 |
| [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia]. | Acta haematologica Polonica 19760101 |
| Letter: Early onset of daunorubicin (daunomycin) cardiotoxicity. | Lancet (London, England) 19751011 |
| [Possibility for the prevention of cardio toxic effect of Cerubidin]. | Orvosi hetilap 19750824 |
| [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases]. | La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris 19750614 |
| Immunosuppressive and cytotoxic chemotherapy: long-term complications. | Annals of internal medicine 19750101 |
| Myocardial injury produced by antineoplastic drugs. | Recent advances in studies on cardiac structure and metabolism 19750101 |
| Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia. | Cancer 19740201 |
| Ultrastructural changes in kidney glomeruli in daunomycin nephrosis. | Annals of the Medical Section of the Polish Academy of Sciences 19740101 |
| [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case]. | Archives francaises de pediatrie 19740101 |
| Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris). | Cancer research 19731201 |
| [Kidney glomerulus of the rat during experimental daunomycin-nephrosis. A comparative transimission and scanning electron microscopic study]. | Beitrage zur Pathologie 19730401 |
| High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia. | Cancer chemotherapy reports 19721201 |
| [Inhibition of pyruvate and alpha ketoglutarate oxidation in the nephrotic syndrome following daunomycin administration in the rat glomerulus]. | Die Medizinische Welt 19721125 |
| [Intraglomerular coenzyme A in daunomycin nephrosis of the rat]. | Die Medizinische Welt 19721125 |
| [57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P]. | La Nouvelle presse medicale 19720923 |
| Daunorubicin. Results in childhood leukaemia. | Archives of disease in childhood 19720401 |
| [Acute heart failure after a moderate dose of rubidomycin]. | La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris 19720208 |
| [Early glomerular changes in daunomycin-nephrosis (author's transl)]. | Verhandlungen der Deutschen Gesellschaft fur Pathologie 19720101 |
| Daunomycin: a cardiotoxic agent. | Journal of the National Medical Association 19710701 |
| Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase. | Padiatrie und Padologie 19710101 |
| Clinical note: allergic reaction to daunomycin (NSC-82151). | Cancer chemotherapy reports 19701201 |
| Role of the sympathetic nervous system in daunomycin-induced arrhythmia in the monkey. | British journal of pharmacology 19700701 |
| Cross-striated fibrils and other ultrastructural alterations in glomeruli of rats with daunomycin nephrosis. | Laboratory investigation; a journal of technical methods and pathology 19700701 |
| [Teratogenic action by rubidomycin in the rat]. | Comptes rendus des seances de la Societe de biologie et de ses filiales 19690101 |
| Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. | Cancer 19670301 |